{
  "Status Epilepticus": {
    "version": "2.0",
    "icd10": "G40.901, G41.0, G41.1, G41.2, G41.8, G41.9",
    "scope": "Management of convulsive status epilepticus (CSE) and non-convulsive status epilepticus (NCSE) in adults. Covers staged treatment protocol from emergent benzodiazepines through refractory and super-refractory phases.",
    "definitions": [
      {
        "term": "Status Epilepticus (SE)",
        "definition": "Seizure lasting >5 minutes OR ‚â•2 seizures without return to baseline between episodes"
      },
      {
        "term": "Refractory SE (RSE)",
        "definition": "SE continuing after adequate doses of initial benzodiazepine AND one second-line ASM"
      },
      {
        "term": "Super-Refractory SE (SRSE)",
        "definition": "SE continuing ‚â•24 hours after anesthetic initiation, including cases that recur during anesthetic weaning"
      },
      {
        "term": "NORSE",
        "definition": "New-Onset Refractory Status Epilepticus - RSE without clear acute/active structural, toxic, or metabolic cause in a patient without prior epilepsy"
      },
      {
        "term": "FIRES",
        "definition": "Febrile Infection-Related Epilepsy Syndrome - subset of NORSE with febrile illness ‚â•24 hours before SE onset"
      }
    ],
    "differential": [
      {
        "diagnosis": "Psychogenic non-epileptic status",
        "features": "Preserved awareness, asynchronous movements, eye closure, pelvic thrusting, prolonged duration with minimal post-ictal period",
        "tests": "Video EEG, normal cEEG during event"
      },
      {
        "diagnosis": "Convulsive syncope",
        "features": "Brief (< 30 sec), occurs with LOC, myoclonic jerks possible",
        "tests": "History of prodrome, rapid recovery, normal EEG"
      },
      {
        "diagnosis": "Movement disorders",
        "features": "Non-rhythmic, preserved awareness, stereotyped pattern",
        "tests": "EEG normal during movements"
      },
      {
        "diagnosis": "Rigors (sepsis)",
        "features": "Associated with fever/chills, rhythmic shaking, preserves awareness",
        "tests": "Infectious workup, temperature"
      },
      {
        "diagnosis": "Decerebrate/decorticate posturing",
        "features": "Associated with structural brain injury, sustained posturing",
        "tests": "Imaging, cEEG"
      },
      {
        "diagnosis": "Neuroleptic malignant syndrome",
        "features": "Rigidity, hyperthermia, AMS, autonomic instability",
        "tests": "CPK, medication history"
      },
      {
        "diagnosis": "Serotonin syndrome",
        "features": "Hyperreflexia, clonus, agitation, fever",
        "tests": "Medication history, clinical features"
      },
      {
        "diagnosis": "Drug-induced dyskinesia",
        "features": "Medication history, stereotyped movements",
        "tests": "Drug levels, history, EEG normal"
      },
      {
        "diagnosis": "Tetanus",
        "features": "Sustained muscle contraction, trismus, opisthotonos",
        "tests": "History of wound, vaccination status"
      },
      {
        "diagnosis": "Strychnine poisoning",
        "features": "Opisthotonus with preserved consciousness",
        "tests": "Toxicology"
      }
    ],
    "notes": [
      "SE is a medical emergency with ~20% mortality; rapid treatment is critical",
      "Every 5-minute delay in treatment associated with worse outcomes",
      "cEEG monitoring essential - up to 48% of patients have non-convulsive seizures after convulsive SE controlled",
      "Levetiracetam dosing: ESETT used 60 mg/kg; 40 mg/kg also acceptable per recent evidence",
      "Ketamine timing: Earlier administration (in RSE, not just SRSE) correlates with better outcomes. Consider using early or in combination with midazolam",
      "NORSE/FIRES: ~50% remain cryptogenic; start immunotherapy within 72 hours even without confirmed etiology. Ketogenic diet by Day 7",
      "Propofol infusion syndrome: metabolic acidosis, rhabdomyolysis, cardiac failure - limit propofol to <48h at high doses",
      "Always have airway equipment ready; many second-line and all third-line agents cause respiratory depression"
    ],
    "evidence": [
      {
        "recommendation": "Benzodiazepines first-line for SE",
        "level": "Class I, Level A",
        "source": "[NCS Guidelines 2012](https://pubmed.ncbi.nlm.nih.gov/22528274/); [AES Guidelines 2016](https://pubmed.ncbi.nlm.nih.gov/26900382/)"
      },
      {
        "recommendation": "Lorazepam preferred IV benzodiazepine",
        "level": "Class I, Level A",
        "source": "[Alldredge et al. NEJM 2001](https://pubmed.ncbi.nlm.nih.gov/11547716/)"
      },
      {
        "recommendation": "IM midazolam non-inferior to IV lorazepam",
        "level": "Class I, Level A",
        "source": "[RAMPART Trial, Silbergleit et al. NEJM 2012](https://pubmed.ncbi.nlm.nih.gov/22335736/)"
      },
      {
        "recommendation": "Second-line agents (LEV, VPA, fPHT) equivalent efficacy",
        "level": "Class I, Level A",
        "source": "[ESETT Trial, Kapur et al. NEJM 2019](https://pubmed.ncbi.nlm.nih.gov/31774955/)"
      },
      {
        "recommendation": "Levetiracetam 60 mg/kg dosing",
        "level": "Class I, Level A",
        "source": "[ESETT Trial](https://pubmed.ncbi.nlm.nih.gov/31774955/) - higher than traditional 20-40 mg/kg"
      },
      {
        "recommendation": "Levetiracetam 40 mg/kg may be adequate",
        "level": "Class II, Level B",
        "source": "Meta-analysis, pharmacokinetic modeling 2023-2024"
      },
      {
        "recommendation": "cEEG monitoring in RSE",
        "level": "Class I, Level B",
        "source": "[NCS Guidelines 2012](https://pubmed.ncbi.nlm.nih.gov/22528274/)"
      },
      {
        "recommendation": "Burst suppression target for RSE",
        "level": "Class IIb, Level C",
        "source": "Expert consensus"
      },
      {
        "recommendation": "Ketamine in RSE/SRSE",
        "level": "Class IIb, Level B",
        "source": "Multiple case series; 2024 systematic reviews"
      },
      {
        "recommendation": "Earlier ketamine = better outcomes",
        "level": "Class II, Level B",
        "source": "2024 two-center study; systematic reviews"
      },
      {
        "recommendation": "Ketamine efficacy in RSE/SRSE",
        "level": "Class IIa, Level B",
        "source": "[Rosati A et al., CNS Drugs 2018;32(11):997-1009](https://pubmed.ncbi.nlm.nih.gov/30232735/)"
      },
      {
        "recommendation": "Ketamine ¬± midazolam superiority over midazolam alone",
        "level": "Class II, Level B",
        "source": "[Fletman et al., Clin Neurol Neurosurg 2024](https://pubmed.ncbi.nlm.nih.gov/39418930/); [Yan et al., J Neurol 2024](https://pubmed.ncbi.nlm.nih.gov/38782798/)"
      },
      {
        "recommendation": "NORSE first-line immunotherapy within 72h",
        "level": "Class IIa, Level C",
        "source": "[Wickstr√∂m et al. Epilepsia 2022](https://pubmed.ncbi.nlm.nih.gov/35997591/)"
      },
      {
        "recommendation": "Ketogenic diet by Day 7 in NORSE",
        "level": "Class IIa, Level C",
        "source": "[International Consensus 2022](https://pubmed.ncbi.nlm.nih.gov/35951466/); FIRES case series"
      },
      {
        "recommendation": "Second-line immunotherapy by Day 7 if first-line fails",
        "level": "Class IIb, Level C",
        "source": "[International Consensus 2022](https://pubmed.ncbi.nlm.nih.gov/35997591/)"
      },
      {
        "recommendation": "Brivaracetam for SE",
        "level": "Class IIb, Level C",
        "source": "Emerging evidence; case series"
      }
    ],
    "appendices": [
      {
        "title": "Time-Based Treatment Algorithm",
        "content": "TIME 0-5 MIN: STABILIZATION + EMERGENT TREATMENT\n‚Ä¢ ABCs: Airway, Breathing, Circulation\n‚Ä¢ Glucose check ‚Üí Dextrose if low + Thiamine\n‚Ä¢ IV access x 2\n‚Ä¢ Lorazepam 0.1 mg/kg IV (max 4 mg) OR Midazolam 10 mg IM\n‚Ä¢ May repeat BZD x1 in 5 min\n\nTIME 5-20 MIN: URGENT/SECOND-LINE (if still seizing)\n‚Ä¢ Choose ONE:\n  - Levetiracetam 40-60 mg/kg IV (max 4500 mg)\n  - Fosphenytoin 20 mg PE/kg IV at 150 mg PE/min\n  - Valproate 40 mg/kg IV (max 3000 mg) - avoid in pregnancy\n  - Lacosamide 400 mg IV\n‚Ä¢ Start cEEG monitoring\n‚Ä¢ CT head if not done\n\nTIME 20-60 MIN: REFRACTORY SE (if still seizing)\n‚Ä¢ Requires ICU and intubation\n‚Ä¢ Initiate anesthetic infusion:\n  - Midazolam: Load 0.2 mg/kg ‚Üí 0.1-2 mg/kg/hr\n  - Propofol: Load 1-2 mg/kg ‚Üí 20-200 mcg/kg/min\n  - Ketamine: Load 1-2 mg/kg ‚Üí 1-5 mg/kg/hr ‚Üê Consider EARLY\n‚Ä¢ Target burst suppression on cEEG\n\nTIME >24 HOURS ON ANESTHETICS: SUPER-REFRACTORY SE\n‚Ä¢ Add additional ASMs (topiramate, perampanel)\n‚Ä¢ Combine anesthetics (midazolam + ketamine)\n‚Ä¢ If NORSE/FIRES ‚Üí See NORSE Protocol\n‚Ä¢ Consider ketogenic diet\n‚Ä¢ Goals of care discussion"
      },
      {
        "title": "NORSE/FIRES Immunotherapy Timeline",
        "content": "DAY 0-3: FIRST-LINE IMMUNOTHERAPY\n‚Ä¢ Methylprednisolone 1000 mg IV daily √ó 3-5 days\n‚Ä¢ ¬± IVIG 0.4 g/kg/day √ó 5 days (can start simultaneously)\n‚Ä¢ Continue ASMs and anesthetics as needed\n\nDAY 3-7: ESCALATE IF NO RESPONSE\n‚Ä¢ Add IVIG if not started\n‚Ä¢ Consider PLEX (5-7 exchanges)\n‚Ä¢ Do not wait for autoimmune results\n\nDAY 7: KEY DECISION POINT\n‚Ä¢ Initiate ketogenic diet\n‚Ä¢ If first-line inadequate ‚Üí Start second-line:\n  - Rituximab 375 mg/m¬≤ weekly √ó 4\n  - OR Cyclophosphamide 750-1000 mg/m¬≤ monthly\n‚Ä¢ Continue supportive care\n\nDAY 7+: ONGOING MANAGEMENT\n‚Ä¢ Continue second-line immunotherapy\n‚Ä¢ Maintain ketogenic diet\n‚Ä¢ Consider tocilizumab or anakinra if refractory\n‚Ä¢ Goals of care discussion if no improvement"
      },
      {
        "title": "Rapid Protocol (3 AM Protocol)",
        "content": "STEP 1: STABILIZATION (Time 0)\n‚òê Call Neurology STAT; alert ICU\n‚òê Position patient, protect head\n‚òê Oxygen: Non-rebreather 15 L/min\n‚òê IV access: Two large-bore IVs\n‚òê Cardiac monitor\n‚òê Fingerstick glucose ‚Üí Dextrose 50% 50mL + Thiamine 100mg if low/unknown\n\nSTEP 2: FIRST-LINE BENZODIAZEPINE (Time 0-5 min)\n‚Ä¢ IV access: Lorazepam 4 mg IV push over 2 min\n‚Ä¢ No IV: Midazolam 10 mg IM\n‚Ä¢ No IV/IM: Midazolam 5 mg each nostril\n‚Üí Wait 5 min. Still seizing? Repeat x1\n‚Üí Wait 5 more min. Still seizing? GO TO STEP 3\nüö´ DO NOT give a third dose of benzodiazepine\n\nSTEP 3: SECOND-LINE ASM (Time 5-20 min)\nDEFAULT: Levetiracetam\n‚Ä¢ 50 kg = 2500 mg IV over 10 min\n‚Ä¢ 60 kg = 3000 mg IV\n‚Ä¢ 70 kg = 3500 mg IV\n‚Ä¢ 80 kg = 4000 mg IV\n‚Ä¢ ‚â•90 kg = 4500 mg IV (max)\n\nALTERNATIVES:\n‚Ä¢ Already on LEV at home ‚Üí Fosphenytoin 20 mg PE/kg IV\n‚Ä¢ Pregnant ‚Üí Use Levetiracetam (avoid valproate)\n‚Ä¢ Cardiac disease ‚Üí Use Levetiracetam (avoid fosphenytoin/lacosamide)\n\nüö® Still seizing at 20 min? ‚Üí CALL ICU NOW, proceed to RSE protocol"
      }
    ],
    "sections": {
      "Laboratory Workup": {
        "Core Labs": [
          {
            "item": "Point-of-care glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypoglycemia is immediately reversible cause"
          },
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Infection screen, baseline before ASMs"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolyte abnormalities, renal/hepatic function for ASM dosing"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia lowers seizure threshold"
          },
          {
            "item": "Calcium (ionized if available)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypocalcemia can cause seizures"
          },
          {
            "item": "Phosphorus",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypophosphatemia lowers seizure threshold"
          },
          {
            "item": "Blood gas (ABG or VBG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Acidosis, oxygenation, ventilation status"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Elevated in prolonged seizure; marker of severity"
          },
          {
            "item": "Urine drug screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Illicit drugs, withdrawal states"
          },
          {
            "item": "Blood alcohol level",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Alcohol withdrawal common cause"
          },
          {
            "item": "ASM levels (if on therapy)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Subtherapeutic levels as precipitant"
          },
          {
            "item": "Pregnancy test (women of childbearing age)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Eclampsia; affects ASM choice"
          }
        ],
        "Extended Workup": [
          {
            "item": "Ammonia",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hepatic encephalopathy, valproate toxicity"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Thyroid storm/myxedema"
          },
          {
            "item": "Troponin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Cardiac stress from prolonged seizure"
          },
          {
            "item": "CPK/CK",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Rhabdomyolysis from prolonged convulsions"
          },
          {
            "item": "Cortisol (random)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Adrenal insufficiency"
          },
          {
            "item": "Serum osmolality",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Hypo/hyperosmolar states"
          },
          {
            "item": "Procalcitonin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "CNS infection if suspected"
          },
          {
            "item": "Coagulation panel (PT/INR, PTT)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Pre-LP, hemorrhage risk"
          },
          {
            "item": "Type and screen",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Anticipate possible surgical intervention"
          },
          {
            "item": "Urinalysis",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "UTI as precipitant (especially elderly)"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Anti-NMDAR, LGI1, CASPR2 in NORSE"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Subacute onset, smoking history, weight loss"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "HIV-associated CNS disease"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Neurosyphilis"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Wilson disease (young patients)"
          },
          {
            "item": "Porphyrins (urine/serum)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Acute intermittent porphyria"
          },
          {
            "item": "Mitochondrial DNA testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "MELAS, other mitochondrial disorders"
          },
          {
            "item": "Pyridoxine trial (empiric)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Pyridoxine-dependent seizures (rare, usually pediatric)"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Rule out structural cause requiring intervention",
            "timing": "As soon as patient stabilized; do not delay treatment",
            "target": "Mass lesion, hemorrhage, stroke, midline shift, herniation"
          },
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Essential - up to 48% have NCSE after convulsive SE controlled",
            "timing": "Initiate within 1 hour of presentation; continue 24-48h after clinical seizure control",
            "target": "Electrographic seizure activity, burst suppression pattern, NCSE"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Aspiration risk high with prolonged seizure and altered consciousness",
            "target": "Aspiration pneumonia, ETT position if intubated"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Superior for encephalitis, subtle lesions, NORSE workup",
            "timing": "When stable enough for MRI; within 24-48h if possible",
            "target": "Encephalitis (temporal lobe signal), stroke, tumor, hippocampal injury",
            "contraindications": "Pacemaker, metal implants - check MRI safety"
          },
          {
            "item": "CT angiography head/neck",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "If stroke suspected as cause of SE",
            "target": "Large vessel occlusion, dissection",
            "contraindications": "Contrast allergy (premedicate); renal insufficiency (hydrate)"
          },
          {
            "item": "MRA/MRV brain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "If vascular etiology suspected",
            "target": "Venous thrombosis, vascular malformation"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "If paraneoplastic suspected",
            "target": "Occult malignancy"
          },
          {
            "item": "Echocardiogram",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "If embolic stroke suspected, endocarditis",
            "target": "Vegetation, thrombus"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT (whole body)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Occult malignancy workup",
            "target": "Tumor identification"
          },
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Refractory cases, suspected encephalitis",
            "target": "Histopathologic diagnosis",
            "contraindications": "Coagulopathy, critical location"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Infection, inflammation",
            "target": "WBC <5; RBC 0"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Elevated in infection, inflammation",
            "target": "15-45 mg/dL"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Low in bacterial/fungal meningitis",
            "target": ">60% serum"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Rapid pathogen identification",
            "target": "Negative"
          },
          {
            "item": "HSV-1/2 PCR",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "HSV encephalitis",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "NORSE, limbic encephalitis",
            "target": "Negative"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative"
          },
          {
            "item": "Oligoclonal bands",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Demyelinating disease",
            "target": "Negative"
          }
        ]
      },
      "Treatment": {
        "Stabilization": [
          {
            "item": "Airway positioning/management",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Head-tilt chin-lift, oral airway, prepare for intubation",
            "rationale": "Protect airway"
          },
          {
            "item": "Supplemental oxygen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Non-rebreather 15 L/min",
            "rationale": "Maintain O2 sat >94%"
          },
          {
            "item": "IV access (two large-bore)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "18G or larger x2",
            "rationale": "Medication administration"
          },
          {
            "item": "Dextrose 50% IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "50 mL IV push (25g) if glucose <70 or unknown",
            "rationale": "Correct hypoglycemia"
          },
          {
            "item": "Thiamine IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "100-500 mg IV BEFORE or WITH glucose",
            "rationale": "Prevent Wernicke encephalopathy"
          },
          {
            "item": "Cardiac monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Continuous telemetry",
            "rationale": "Monitor for arrhythmias; ASMs can affect cardiac conduction",
            "monitoring": "Rhythm, HR, BP"
          },
          {
            "item": "Isotonic fluids",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "NS or LR wide open initially",
            "rationale": "Volume resuscitation, medication administration",
            "contraindications": "Pulmonary edema",
            "monitoring": "BP, I/O"
          }
        ],
        "First-Line (Benzodiazepines)": [
          {
            "item": "Lorazepam IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "4 mg IV push over 2 min; may repeat x1 in 5 min; max 8 mg total",
            "rationale": "First-line if IV access available; Class I evidence",
            "timing": "Administer within 5 min of seizure onset",
            "target": "Cessation of clinical and electrographic seizure activity",
            "contraindications": "Acute narrow-angle glaucoma; severe respiratory depression without ventilator support",
            "monitoring": "Respiratory status, BP, sedation level; have airway equipment ready"
          },
          {
            "item": "Midazolam IM",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "10 mg IM single dose (if no IV access)",
            "rationale": "First-line if no IV access; RAMPART trial showed non-inferior to IV lorazepam",
            "timing": "Administer immediately if no IV access",
            "target": "Cessation of clinical seizure activity",
            "monitoring": "Respiratory status; onset 5-15 min"
          },
          {
            "item": "Midazolam IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "0.2 mg/kg IV (max 10 mg); may repeat x1",
            "rationale": "Alternative IV benzodiazepine; faster onset than lorazepam",
            "timing": "Administer within 5 min of seizure onset",
            "target": "Cessation of clinical and electrographic seizure activity",
            "contraindications": "Acute narrow-angle glaucoma; severe respiratory depression",
            "monitoring": "RR, O2 sat, BP"
          },
          {
            "item": "Midazolam intranasal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "5 mg per nostril (10 mg total)",
            "rationale": "Alternative if no IV/IM access; useful for bystander administration",
            "timing": "Administer immediately; onset 10-15 min",
            "target": "Cessation of clinical seizure activity",
            "contraindications": "Nasal obstruction",
            "monitoring": "RR, O2 sat"
          },
          {
            "item": "Midazolam buccal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "10 mg buccal (if available)",
            "rationale": "Alternative if no IV access; useful in community setting",
            "timing": "Administer immediately if no IV/IM access",
            "target": "Cessation of clinical seizure activity",
            "contraindications": "Oral trauma",
            "monitoring": "RR, O2 sat"
          },
          {
            "item": "Diazepam IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "0.15 mg/kg IV (max 10 mg); may repeat x1 in 5 min",
            "rationale": "Alternative IV benzodiazepine; shorter duration requires follow-up ASM",
            "timing": "Administer within 5 min of seizure onset",
            "target": "Cessation of clinical seizure activity",
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat; short duration - requires follow-up ASM"
          },
          {
            "item": "Diazepam rectal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "0.2-0.5 mg/kg PR (max 20 mg); use rectal gel formulation",
            "rationale": "Alternative if no IV/IM access; useful for home/EMS use",
            "timing": "Administer immediately if no other access",
            "target": "Cessation of clinical seizure activity",
            "contraindications": "Rectal pathology",
            "monitoring": "RR, O2 sat"
          }
        ],
        "Second-Line ASMs": [
          {
            "item": "Levetiracetam IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "50-60 mg/kg IV (max 4500 mg) over 10-15 min",
            "rationale": "Preferred - fewest drug interactions, no cardiac monitoring needed",
            "timing": "Give at 5-10 min if BZD fails; infuse over 10-15 min",
            "target": "Seizure cessation; therapeutic level not needed acutely",
            "contraindications": "None absolute; reduce dose if CrCl <50",
            "monitoring": "None required during acute administration"
          },
          {
            "item": "Fosphenytoin IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "20 mg PE/kg IV at 150 mg PE/min",
            "rationale": "Alternative - equivalent efficacy per ESETT",
            "timing": "Give at 5-10 min if BZD fails; infusion takes ~15 min",
            "target": "Total phenytoin level 10-20 mcg/mL; free level 1-2 mcg/mL",
            "contraindications": "2nd/3rd degree AV block; sinus bradycardia; Adams-Stokes syndrome",
            "monitoring": "Continuous cardiac monitoring during infusion; BP q5min"
          },
          {
            "item": "Valproate IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "40 mg/kg IV (max 3000 mg) over 10 min",
            "rationale": "Alternative - equivalent efficacy per ESETT",
            "timing": "Give at 5-10 min if BZD fails",
            "target": "Seizure cessation; level 80-120 mcg/mL",
            "contraindications": "PREGNANCY (teratogenic); hepatic disease; urea cycle disorders; mitochondrial disease (POLG mutations)",
            "monitoring": "LFTs, ammonia if altered mental status persists"
          },
          {
            "item": "Lacosamide IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "400 mg IV over 15 min",
            "rationale": "Alternative - not in ESETT but increasingly used",
            "timing": "Give at 5-10 min if BZD fails",
            "target": "Seizure cessation",
            "contraindications": "2nd/3rd degree AV block without pacemaker; PR interval >200ms",
            "monitoring": "ECG - check PR interval before and after"
          },
          {
            "item": "Levetiracetam IV (conservative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "40 mg/kg IV (max 4500 mg) over 10-15 min",
            "rationale": "Alternative lower dosing; some institutions prefer this over ESETT 60 mg/kg",
            "timing": "Give at 5-10 min if BZD fails",
            "target": "Seizure cessation",
            "contraindications": "None absolute; reduce if CrCl <50",
            "monitoring": "Generally well tolerated; agitation"
          },
          {
            "item": "Brivaracetam IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "100-200 mg IV over 2-5 min; no titration needed",
            "rationale": "Faster onset than levetiracetam; fewer behavioral effects; useful if patient on home levetiracetam",
            "timing": "Give at 5-10 min if BZD fails",
            "target": "Seizure cessation",
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Generally well tolerated"
          },
          {
            "item": "Phenytoin IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "20 mg/kg IV at max 50 mg/min (if fosphenytoin unavailable)",
            "rationale": "Alternative if fosphenytoin unavailable; same efficacy but more infusion risks",
            "timing": "Give at 5-10 min if BZD fails",
            "target": "Seizure cessation; level 10-20 mcg/mL",
            "contraindications": "2nd/3rd degree AV block; sinus bradycardia",
            "monitoring": "Cardiac monitor; MUST use large vein - tissue necrosis risk with extravasation"
          },
          {
            "item": "Phenobarbital IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "15-20 mg/kg IV at 50-100 mg/min",
            "rationale": "Highly effective but significant respiratory depression; often requires intubation",
            "timing": "Give at 5-10 min if BZD fails; have airway ready",
            "target": "Seizure cessation; level 20-40 mcg/mL",
            "contraindications": "Severe respiratory disease; porphyria",
            "monitoring": "Respiratory status - often requires intubation at full dose; sedation"
          }
        ],
        "Refractory SE (Anesthetics)": [
          {
            "item": "Midazolam infusion",
            "ED": "URGENT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Load 0.2 mg/kg bolus; then 0.1 mg/kg/hr, titrate to burst suppression; max 2 mg/kg/hr",
            "rationale": "First-line anesthetic for RSE; less hypotension than propofol",
            "timing": "Initiate at 20-60 min if still seizing after second-line ASM",
            "target": "Burst suppression on cEEG (1-2 bursts per 10 sec)",
            "contraindications": "None absolute in RSE",
            "monitoring": "cEEG continuous; BP, HR continuous; sedation assessment q4h"
          },
          {
            "item": "Ketamine infusion",
            "ED": "URGENT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Load 1-2 mg/kg bolus; then 1-5 mg/kg/hr",
            "rationale": "NMDA antagonist - different mechanism; GIVE EARLY for better outcomes",
            "timing": "Consider early in RSE, not just SRSE; can combine with midazolam",
            "target": "Seizure cessation; may not need burst suppression",
            "contraindications": "Severe uncontrolled HTN; conditions where increased ICP is harmful",
            "monitoring": "cEEG; BP (may cause hypertension); secretions"
          },
          {
            "item": "Propofol infusion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Load 1-2 mg/kg; then 20-200 mcg/kg/min; limit <48h at high dose",
            "rationale": "Alternative - rapid onset/offset but risk of PRIS",
            "timing": "Initiate at 20-60 min if still seizing",
            "target": "Burst suppression on cEEG",
            "contraindications": "Propofol allergy; caution in children; caution if >48h needed",
            "monitoring": "PROPOFOL INFUSION SYNDROME: check triglycerides, lactate, CPK daily; limit duration"
          },
          {
            "item": "Ketamine + Midazolam (combination)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Ketamine load 1 mg/kg + Midazolam load 0.2 mg/kg; then dual infusions",
            "rationale": "2024 data: combination may reduce SE duration faster than midazolam alone",
            "target": "Seizure cessation",
            "monitoring": "cEEG; hemodynamics"
          },
          {
            "item": "Pentobarbital infusion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Load 5-15 mg/kg IV at 50 mg/min; then 0.5-1 mg/kg/hr, titrate to burst suppression; max 5 mg/kg/hr",
            "rationale": "Most potent but worst hemodynamic effects; reserve for SRSE",
            "target": "Burst suppression on cEEG",
            "contraindications": "Severe cardiac dysfunction",
            "monitoring": "cEEG, BP (significant hypotension - need pressors), cardiac output"
          }
        ],
        "Super-Refractory SE": [
          {
            "item": "Add second anesthetic",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Combine midazolam + propofol, or add ketamine to either",
            "rationale": "Seizures continue ‚â•24h after anesthetic initiation",
            "monitoring": "cEEG, hemodynamics"
          },
          {
            "item": "Topiramate (enteral)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "dosing": "Load 300-400 mg via NGT; then 200-400 mg BID; max 1600 mg/day",
            "rationale": "Adjunctive ASM for SRSE",
            "contraindications": "Metabolic acidosis, kidney stones",
            "monitoring": "Bicarbonate, renal function"
          },
          {
            "item": "Lacosamide (if not tried)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "dosing": "400 mg IV, then 200-400 mg BID",
            "contraindications": "PR prolongation",
            "monitoring": "ECG"
          },
          {
            "item": "Perampanel (enteral)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "dosing": "4-8 mg via NGT daily; titrate to 12 mg daily",
            "rationale": "AMPA antagonist",
            "monitoring": "Aggression, sedation"
          },
          {
            "item": "Magnesium sulfate infusion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "dosing": "4-6 g IV over 20 min, then 1-2 g/hr; target Mg 3.5-4 mg/dL",
            "contraindications": "Renal failure (relative), myasthenia",
            "monitoring": "Mg levels, reflexes, respiratory status"
          },
          {
            "item": "Pyridoxine (empiric trial)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "dosing": "100-500 mg IV; may try single dose empirically",
            "rationale": "Pyridoxine-dependent seizures"
          },
          {
            "item": "Ketogenic diet",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "dosing": "Initiate within 7 days per NORSE consensus; requires nutrition support",
            "contraindications": "Pyruvate carboxylase deficiency, fatty acid oxidation disorders",
            "monitoring": "Ketones, glucose, lipids"
          },
          {
            "item": "Hypothermia (32-35¬∞C)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "dosing": "Targeted temperature management x 24-48h",
            "contraindications": "Coagulopathy, severe infection",
            "monitoring": "Temperature, coagulation, infection"
          },
          {
            "item": "Electroconvulsive therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "dosing": "If all else fails; requires anesthesia",
            "contraindications": "Raised ICP, recent stroke"
          },
          {
            "item": "Epilepsy surgery (emergent)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "dosing": "Resection if focal lesion identified",
            "contraindications": "Eloquent cortex, multifocal"
          }
        ],
        "NORSE/FIRES First-Line Immunotherapy": [
          {
            "item": "Methylprednisolone IV",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "1000 mg IV daily √ó 3-5 days",
            "rationale": "Start within 72 hours if no clear etiology",
            "contraindications": "Active untreated infection (relative)",
            "monitoring": "Glucose q6h, BP, GI prophylaxis, infection signs"
          },
          {
            "item": "IVIG",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "0.4 g/kg/day IV √ó 5 days (total 2 g/kg); can give simultaneously with steroids",
            "contraindications": "IgA deficiency (use IgA-depleted product), renal failure, thrombosis risk",
            "monitoring": "Renal function, signs of aseptic meningitis, thrombosis"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "5-7 exchanges over 10-14 days; 1-1.5 plasma volumes per exchange",
            "contraindications": "Hemodynamic instability, line access issues",
            "monitoring": "Hemodynamics, electrolytes (Ca, Mg), coagulation, fibrinogen"
          }
        ],
        "NORSE/FIRES Second-Line Immunotherapy": [
          {
            "item": "Rituximab",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "dosing": "375 mg/m¬≤ IV weekly √ó 4 doses",
            "rationale": "If first-line fails by Day 7",
            "contraindications": "Active infection, hepatitis B (screen first)",
            "monitoring": "Infusion reactions, infection, B-cell counts"
          },
          {
            "item": "Cyclophosphamide",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "dosing": "750-1000 mg/m¬≤ IV monthly √ó 3-6 months",
            "contraindications": "Severe cytopenias, active infection",
            "monitoring": "CBC weekly, renal function, hemorrhagic cystitis (hydration + mesna)"
          },
          {
            "item": "Tocilizumab",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "dosing": "8 mg/kg IV q4 weeks (emerging option)",
            "contraindications": "Active infection, hepatic impairment",
            "monitoring": "LFTs, lipids, infection"
          },
          {
            "item": "Anakinra",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "dosing": "100 mg SC daily (may increase; used in FIRES)",
            "contraindications": "Active infection",
            "monitoring": "Injection site reactions, infection"
          }
        ],
        "Symptomatic/Supportive ICU Care": [
          {
            "item": "Norepinephrine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Start 0.1 mcg/kg/min; titrate to MAP ‚â•65",
            "rationale": "Hypotension from anesthetics",
            "contraindications": "Hypovolemia (correct first)",
            "monitoring": "Arterial line, MAP"
          },
          {
            "item": "Vasopressin",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "0.04 units/min fixed dose",
            "rationale": "Adjunct pressor",
            "contraindications": "Cardiac ischemia",
            "monitoring": "MAP, cardiac status"
          },
          {
            "item": "Fentanyl infusion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "dosing": "25-100 mcg/hr; titrate to comfort",
            "rationale": "Analgesia/sedation adjunct",
            "contraindications": "Hemodynamic instability",
            "monitoring": "Pain scale, respiratory status"
          },
          {
            "item": "Propofol (sub-anesthetic)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "dosing": "5-50 mcg/kg/min",
            "rationale": "Sedation during cEEG",
            "contraindications": "Same as anesthetic use",
            "monitoring": "Sedation scale"
          },
          {
            "item": "Dexmedetomidine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "dosing": "0.2-1.5 mcg/kg/hr",
            "rationale": "Sedation, possible antiseizure properties",
            "contraindications": "Bradycardia, heart block",
            "monitoring": "HR, BP"
          },
          {
            "item": "Pantoprazole",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "40 mg IV daily",
            "rationale": "Stress ulcer prophylaxis",
            "monitoring": "GI bleeding"
          },
          {
            "item": "Enoxaparin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "40 mg SC daily (start when stable)",
            "rationale": "DVT prophylaxis",
            "contraindications": "Active bleeding, recent LP",
            "monitoring": "Platelets, bleeding"
          },
          {
            "item": "Insulin infusion",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Per ICU protocol; target glucose 140-180 mg/dL",
            "rationale": "Stress hyperglycemia",
            "contraindications": "Hypoglycemia",
            "monitoring": "Glucose q1-4h"
          },
          {
            "item": "Bowel regimen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "dosing": "Docusate 100 mg BID + senna 8.6 mg daily; escalate PRN",
            "rationale": "Constipation prophylaxis",
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements"
          },
          {
            "item": "Skin care protocol",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Turn q2h, specialty mattress, moisture barrier, Braden scale assessment",
            "rationale": "Pressure injury prevention",
            "monitoring": "Skin integrity daily"
          },
          {
            "item": "Eye care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Lubricating drops q4h, eyelid taping if incomplete closure",
            "rationale": "Corneal protection",
            "monitoring": "Corneal integrity"
          }
        ]
      },
      "Referrals & Consults": {
        "Consults": [
          {
            "item": "Neurology/Epilepsy STAT consult",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "All cases of SE"
          },
          {
            "item": "Neurocritical care consult",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "RSE/SRSE, need for anesthetic infusions"
          },
          {
            "item": "ICU admission",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "All SE requiring second-line agents or ongoing seizures"
          },
          {
            "item": "EEG technologist/cEEG initiation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Mandatory for RSE/SRSE; strongly recommended for all SE"
          },
          {
            "item": "Infectious disease consult",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Suspected CNS infection"
          },
          {
            "item": "Rheumatology/Neuroimmunology consult",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "NORSE/FIRES, suspected autoimmune encephalitis"
          },
          {
            "item": "Pharmacy consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Complex ASM dosing, drug interactions"
          },
          {
            "item": "Nutrition/Dietitian consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Enteral feeding, ketogenic diet initiation (by Day 7 in NORSE)"
          },
          {
            "item": "Palliative care consult",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "SRSE with poor prognosis, goals of care discussion"
          },
          {
            "item": "Social work consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Family support, discharge planning"
          },
          {
            "item": "Epilepsy surgery evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "EXT",
            "rationale": "Focal lesion on imaging, refractory to medical therapy"
          },
          {
            "item": "PT/OT/Speech evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Once stabilized; assess for deficits"
          },
          {
            "item": "Epilepsy outpatient follow-up",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "All SE survivors; ASM optimization, etiology workup"
          },
          {
            "item": "Outpatient video-EEG monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Characterization of seizure type, presurgical evaluation"
          },
          {
            "item": "Neuropsychology testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Cognitive assessment post-SE; baseline before surgery"
          }
        ]
      },
      "Patient Instructions": {
        "Education": [
          {
            "item": "Explain SE is a medical emergency requiring ICU care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Family understanding of severity"
          },
          {
            "item": "Discuss prognosis based on etiology and duration of SE",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Realistic expectations"
          },
          {
            "item": "Educate on importance of ASM adherence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Prevent recurrence if applicable"
          },
          {
            "item": "Seizure first aid education for family",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Safety during future seizures"
          },
          {
            "item": "Rescue medication training (rectal diazepam, nasal midazolam)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Empower family for seizure emergencies"
          },
          {
            "item": "Driving restrictions (minimum 3-6 months seizure-free)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Legal requirement; varies by state"
          },
          {
            "item": "Medical alert bracelet recommendation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Emergency identification"
          },
          {
            "item": "Seizure action plan development",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Structured emergency response"
          },
          {
            "item": "Discuss goals of care if SRSE with poor prognosis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "End-of-life planning when appropriate"
          }
        ]
      },
      "Lifestyle": {
        "Prevention": [
          {
            "item": "Medication adherence counseling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "ASM non-adherence is common SE precipitant"
          },
          {
            "item": "Avoid abrupt ASM discontinuation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Common SE precipitant"
          },
          {
            "item": "Alcohol cessation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Alcohol lowers seizure threshold; withdrawal causes seizures"
          },
          {
            "item": "Sleep hygiene",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Sleep deprivation lowers seizure threshold"
          },
          {
            "item": "Avoid known seizure triggers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Patient-specific triggers"
          },
          {
            "item": "Drug interaction review",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "OTC meds and supplements can affect ASM levels"
          },
          {
            "item": "Pregnancy planning counseling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Women of childbearing potential; teratogenic ASMs"
          }
        ]
      },
      "Monitoring Parameters": {
        "Continuous Monitoring": [
          {
            "item": "Continuous EEG",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "Continuous",
            "target": "No seizures; burst suppression if on anesthetics",
            "rationale": "Detect ongoing seizures, NCSE"
          },
          {
            "item": "Cardiac telemetry",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "Continuous",
            "target": "Normal rhythm, HR 60-100",
            "rationale": "Arrhythmia from ASMs, electrolyte shifts"
          },
          {
            "item": "Pulse oximetry",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "Continuous",
            "target": "O2 sat >94%",
            "rationale": "Respiratory depression from sedatives"
          },
          {
            "item": "Blood pressure",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "q5min during treatment, then q1h",
            "target": "MAP ‚â•65; avoid severe hypertension",
            "rationale": "Hypotension from anesthetics; hypertension from seizures"
          }
        ],
        "Intermittent Monitoring": [
          {
            "item": "Neurologic exam",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "q1-2h when off sedation",
            "target": "Return to baseline",
            "rationale": "Track recovery, detect new deficits"
          },
          {
            "item": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "q1-4h",
            "target": "140-180 mg/dL (ICU)",
            "rationale": "Stress hyperglycemia common"
          },
          {
            "item": "Electrolytes (Na, K, Mg, Ca, Phos)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "q6-12h",
            "target": "Normal ranges",
            "rationale": "Electrolyte shifts can trigger seizures"
          },
          {
            "item": "ABG/VBG",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "q4-6h (RSE), PRN",
            "target": "pH >7.25, CO2 35-45",
            "rationale": "Respiratory and metabolic status"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "q6-12h",
            "target": "Trending down",
            "rationale": "Marker of seizure activity and tissue perfusion"
          },
          {
            "item": "ASM levels",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "frequency": "24h after load, then PRN",
            "target": "Therapeutic range",
            "rationale": "Guide dosing adjustments"
          },
          {
            "item": "Ammonia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "q24h if on valproate",
            "target": "<35 Œºmol/L",
            "rationale": "Valproate-induced hyperammonemia"
          },
          {
            "item": "LFTs",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "frequency": "q24-48h",
            "target": "Normal",
            "rationale": "Hepatically-metabolized ASMs"
          },
          {
            "item": "Renal function",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "q24h",
            "target": "Normal",
            "rationale": "Renally-cleared ASMs"
          },
          {
            "item": "CPK",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "q12-24h if prolonged convulsions",
            "target": "Trending down",
            "rationale": "Rhabdomyolysis risk"
          },
          {
            "item": "Triglycerides",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "frequency": "q24-48h if on propofol",
            "target": "<400 mg/dL",
            "rationale": "Propofol infusion syndrome"
          },
          {
            "item": "Temperature",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "q4h",
            "target": "36-38¬∞C",
            "rationale": "Fever workup; hyperthermia worsens neuronal injury"
          },
          {
            "item": "ICP (if monitored)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "frequency": "Continuous",
            "target": "<20 mmHg",
            "rationale": "If ICP monitor placed"
          }
        ]
      },
      "Disposition Criteria": {
        "Criteria": [
          {
            "disposition": "ICU admission (REQUIRED)",
            "criteria": "All SE requiring second-line ASMs; all RSE/SRSE; altered mental status; need for airway management; hemodynamic instability"
          },
          {
            "disposition": "Step-down/Telemetry",
            "criteria": "Seizures controlled x 24h, off anesthetics x 24h, stable neuro exam, no airway concerns"
          },
          {
            "disposition": "General floor",
            "criteria": "Seizures controlled, off continuous monitoring, stable on oral ASMs, resolved AMS"
          },
          {
            "disposition": "Discharge home",
            "criteria": "Seizures controlled, stable on oral ASM regimen, etiology identified and addressed, family educated, follow-up arranged"
          },
          {
            "disposition": "Transfer to higher level care",
            "criteria": "Need for services unavailable (cEEG, neurocritical care, epilepsy surgery evaluation)"
          },
          {
            "disposition": "Long-term care/Rehab",
            "criteria": "Persistent deficits after prolonged SE, need for ongoing rehabilitation"
          },
          {
            "disposition": "Palliative/Hospice",
            "criteria": "SRSE with irreversible brain injury, goals of care established"
          }
        ]
      }
    }
  },
  "New Onset Seizure": {
    "id": "new-onset-seizure",
    "title": "New Onset Seizure",
    "version": "1.2",
    "icd10": [
      "** R56.9 (Unspecified convulsions)",
      "G40.909 (Epilepsy",
      "unspecified",
      "not intractable",
      "without status epilepticus)"
    ],
    "scope": "** Initial evaluation and management of first-time unprovoked seizure or first presentation of seizure activity in adults. Covers immediate stabilization, diagnostic workup to identify etiology, acute treatment, and framework for anti-seizure medication (ASM) initiation. Excludes status epilepticus (see \"Status Epilepticus\" template), pediatric seizures, febrile seizures, and known epilepsy with breakthrough seizures.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "rationale": "Hypoglycemia is immediately reversible cause",
            "target": ">70 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before ASMs",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolyte abnormalities (Na, Ca, Mg, glucose), renal/hepatic function for ASM dosing",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia lowers seizure threshold",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Calcium (ionized if available)",
            "rationale": "Hypocalcemia can cause seizures",
            "target": "Normal (ionized 4.5-5.3 mg/dL)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Illicit drugs (cocaine, amphetamines) and withdrawal states",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Blood alcohol level",
            "rationale": "Alcohol intoxication or withdrawal",
            "target": "Correlate with history",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI can provoke seizures (especially elderly)",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Prolactin level",
            "rationale": "Elevated if drawn within 10-20 min of event; helps distinguish seizure from non-epileptic event",
            "target": "Elevated 2-3√ó baseline (if drawn <20 min)",
            "ED": "STAT",
            "HOSP": "‚Äî",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia lowers seizure threshold (especially alcohol withdrawal)",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Lactate",
            "rationale": "Elevated post-ictal confirms recent seizure; metabolic acidosis screen",
            "target": "Mild elevation acceptable post-ictal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can affect seizure threshold",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Ammonia",
            "rationale": "Hepatic encephalopathy, urea cycle disorders",
            "target": "Normal (<35 Œºmol/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          },
          {
            "item": "Troponin",
            "rationale": "Cardiac ischemia as cause or consequence",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          },
          {
            "item": "ECG",
            "rationale": "Arrhythmia, prolonged QTc (some ASMs), Brugada",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Blood gas (ABG or VBG)",
            "rationale": "Acidosis, hypoxia",
            "target": "Normal or mild post-ictal acidosis",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          },
          {
            "item": "Serum osmolality",
            "rationale": "Hypo/hyperosmolar states",
            "target": "280-295 mOsm/kg",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          },
          {
            "item": "Pregnancy test (urine or serum Œ≤-hCG)",
            "rationale": "Eclampsia; affects imaging and ASM choice",
            "target": "Negative (or explains eclampsia if positive)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "B12 level",
            "rationale": "Deficiency associated with seizures",
            "target": "Normal (>300 pg/mL)",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Folate level",
            "rationale": "Deficiency can lower threshold; important for women of childbearing potential",
            "target": "Normal",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum/urine toxicology (expanded panel)",
            "rationale": "Synthetic drugs, medications not on standard screen",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "URGENT"
          },
          {
            "item": "Heavy metals (lead, mercury)",
            "rationale": "Occupational exposure, pica",
            "target": "Normal",
            "ED": "‚Äî",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal",
            "ED": "‚Äî",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated CNS disease",
            "target": "Negative",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "rationale": "Anti-NMDAR, LGI1, CASPR2, GABA-B if clinical suspicion",
            "target": "Negative",
            "ED": "‚Äî",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "rationale": "Subacute onset, smoking, weight loss",
            "target": "Negative",
            "ED": "‚Äî",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "Porphyrins (urine/serum)",
            "rationale": "Acute intermittent porphyria",
            "target": "Normal",
            "ED": "‚Äî",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "Genetic epilepsy panel",
            "rationale": "Young onset, family history, refractory",
            "target": "Variable",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "EXT",
            "ICU": "‚Äî"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "timing": "Immediate in ED",
            "target": "Mass, hemorrhage, stroke, calcification, hydrocephalus",
            "contraindications": "Pregnancy (relative - benefit usually outweighs risk)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "MRI brain with and without contrast (epilepsy protocol)*",
            "timing": "Within 24-48h if inpatient; within 2 weeks if outpatient",
            "target": "Tumor, mesial temporal sclerosis, cortical dysplasia, encephalitis, stroke, vascular malformation",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "EEG (routine)",
            "timing": "Within 24h if possible; ideally within 24-48h of seizure",
            "target": "Epileptiform discharges (spikes, sharp waves), focal slowing",
            "contraindications": "None significant",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "timing": "If altered mental status persists, suspected non-convulsive status",
            "target": "Non-convulsive seizures, non-convulsive status epilepticus",
            "contraindications": "None significant",
            "ED": "‚Äî",
            "HOSP": "URGENT",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          },
          {
            "item": "Prolonged ambulatory EEG (24-72h)",
            "timing": "Outpatient if routine EEG non-diagnostic",
            "target": "Capture interictal or ictal activity",
            "contraindications": "None significant",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Video-EEG monitoring",
            "timing": "If diagnosis uncertain (vs. psychogenic)",
            "target": "Correlate clinical events with EEG",
            "contraindications": "None significant",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "MRA/MRV brain",
            "timing": "If vascular etiology suspected",
            "target": "AVM, aneurysm, venous thrombosis",
            "contraindications": "Same as MRI",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "CT angiography head",
            "timing": "If MRA unavailable and vascular cause suspected",
            "target": "Vascular malformation, aneurysm",
            "contraindications": "Contrast allergy, renal insufficiency",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          },
          {
            "item": "Echocardiogram",
            "timing": "If embolic stroke suspected as cause",
            "target": "Thrombus, PFO, vegetation",
            "contraindications": "None significant",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Chest X-ray",
            "timing": "Aspiration risk post-ictal, lung cancer screening if paraneoplastic suspected",
            "target": "Clear lungs or mass",
            "contraindications": "None significant",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT brain (interictal FDG)",
            "timing": "Epilepsy surgery workup",
            "target": "Focal hypometabolism",
            "contraindications": "Pregnancy, uncontrolled diabetes",
            "ED": "‚Äî",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "SPECT (ictal/interictal)",
            "timing": "Epilepsy surgery workup",
            "target": "Ictal hyperperfusion",
            "contraindications": "Requires seizure capture",
            "ED": "‚Äî",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "MEG (magnetoencephalography)",
            "timing": "Epilepsy surgery workup",
            "target": "Localize epileptogenic focus",
            "contraindications": "Metallic implants",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "Neuropsychological testing",
            "timing": "Pre-surgical evaluation, cognitive concerns",
            "target": "Lateralizing deficits",
            "contraindications": "Patient cooperation",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "Wada test (intracarotid amobarbital)",
            "timing": "Pre-surgical language/memory lateralization",
            "target": "Language and memory dominance",
            "contraindications": "Contrast allergy, vascular anomaly",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "EXT",
            "ICU": "‚Äî"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Elevated ICP, mass effect",
            "target": "10-20 cm H2O",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Infection, inflammation",
            "target": "WBC <5; RBC 0",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in infection, inflammation",
            "target": "15-45 mg/dL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Low in bacterial/fungal/TB meningitis",
            "target": ">60% serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Bacterial meningitis",
            "target": "No organisms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "rationale": "Rapid pathogen identification (14 pathogens)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          },
          {
            "item": "HSV-1/2 PCR",
            "rationale": "HSV encephalitis (most common treatable cause)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "rationale": "If clinical suspicion for autoimmune etiology",
            "target": "Negative",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Cytology",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "VDRL (CSF)",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "If demyelinating disease suspected",
            "target": "Negative or matched with serum",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Lorazepam IV/IM (if actively seizing)",
            "dosing": "0.1 mg/kg IV (max 4 mg); may repeat once in 5 min",
            "contraindications": "Respiratory depression, severe hypotension",
            "monitoring": "RR, O2 sat, BP; have airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IM (if no IV access)",
            "dosing": "10 mg IM (if >40 kg) or 0.2 mg/kg IM",
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat; have airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam intranasal (if no IV access)",
            "dosing": "5 mg per nostril (total 10 mg)",
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Dextrose 50% IV",
            "dosing": "25-50 mL IV if hypoglycemia confirmed or suspected",
            "contraindications": "Hyperglycemia",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine IV",
            "dosing": "100-500 mg IV BEFORE glucose if alcohol use suspected",
            "contraindications": "None significant",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "dosing": "2-4 L NC or non-rebreather as needed",
            "contraindications": "None",
            "monitoring": "O2 sat >94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids (isotonic)",
            "dosing": "NS or LR bolus if hypotensive; maintenance if euvolemic",
            "contraindications": "Fluid overload, severe hyponatremia",
            "monitoring": "I/O, BP, Na",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Flumazenil (rescue only)",
            "dosing": "0.2 mg IV over 30 sec; may repeat 0.2 mg q1min to max 1 mg",
            "contraindications": "Chronic benzodiazepine use; seizure history; tricyclic overdose",
            "monitoring": "**CAUTION:** May lower seizure threshold and precipitate seizures; use only if severe respiratory depression unresponsive to supportive care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          }
        ],
        "Anti-Seizure Medications (ASMs) - Acute Loading": [
          {
            "item": "Levetiracetam IV",
            "indication": "First-line acute loading",
            "dosing": "40-60 mg/kg IV (max 4500 mg) over 15 min; OR 1500-3000 mg IV",
            "contraindications": "None significant; reduce dose if CrCl <50",
            "monitoring": "Somnolence, agitation (rare)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam PO",
            "indication": "Acute loading if stable",
            "dosing": "1500-3000 mg PO √ó 1, then start maintenance",
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "‚Äî"
          },
          {
            "item": "Fosphenytoin IV",
            "indication": "Alternative first-line",
            "dosing": "20 mg PE/kg IV at 150 mg PE/min (max rate)",
            "contraindications": "AV block, sinus bradycardia, pregnancy (relative)",
            "monitoring": "Continuous cardiac monitoring, BP; purple glove syndrome rare with fosphenytoin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin IV",
            "indication": "If fosphenytoin unavailable",
            "dosing": "20 mg/kg IV at max 50 mg/min",
            "contraindications": "AV block, sinus bradycardia, pregnancy",
            "monitoring": "Cardiac monitor, BP; give via large vein (tissue necrosis risk)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Valproate IV",
            "indication": "Alternative (broad-spectrum)",
            "dosing": "40 mg/kg IV over 10 min (max 3000 mg)",
            "contraindications": "Pregnancy (teratogenic - neural tube defects), hepatic disease, mitochondrial disease, urea cycle disorders",
            "monitoring": "LFTs, ammonia, platelets; pancreatitis risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "‚Äî",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide IV",
            "indication": "Alternative first-line",
            "dosing": "200-400 mg IV over 15-30 min",
            "contraindications": "PR prolongation >200 ms, 2nd/3rd degree AV block",
            "monitoring": "ECG for PR interval; dizziness",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          }
        ],
        "Anti-Seizure Medications (ASMs) - Maintenance Therapy": [
          {
            "item": "Levetiracetam",
            "indication": "First-line maintenance",
            "dosing": "500-1500 mg PO/IV BID; start 500 mg BID, may increase by 500 mg/dose weekly; max 3000 mg/day",
            "contraindications": "Renal impairment (adjust per CrCl)",
            "monitoring": "Behavioral changes (irritability, depression - \"Keppra rage\"); renal function",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Lamotrigine",
            "indication": "First-line (especially women of childbearing potential)",
            "dosing": "Start 25 mg daily √ó 2 weeks; then 50 mg daily √ó 2 weeks; then 100 mg daily; target 200-400 mg/day in divided doses",
            "contraindications": "Slow titration required (SJS/TEN risk)",
            "monitoring": "Rash (stop if any rash; SJS/TEN risk higher with fast titration or valproate co-therapy)",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Lacosamide",
            "indication": "First-line alternative",
            "dosing": "Start 100 mg PO BID; increase by 100 mg/day weekly; target 200-400 mg BID; max 400 mg BID",
            "contraindications": "PR prolongation, 2nd/3rd degree AV block, severe hepatic impairment",
            "monitoring": "ECG at baseline and dose changes; dizziness, diplopia",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oxcarbazepine",
            "indication": "Focal seizures",
            "dosing": "Start 300 mg PO BID; increase by 300-600 mg/day every week; target 1200-2400 mg/day in divided doses",
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia in 2-3%); HLA-B*1502 screening in at-risk populations",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Carbamazepine",
            "indication": "Focal seizures",
            "dosing": "Start 200 mg PO BID; increase by 200 mg/day weekly; target 800-1200 mg/day; max 1600 mg/day",
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Valproate/Divalproex",
            "indication": "Generalized seizures",
            "dosing": "Start 10-15 mg/kg/day in divided doses; increase by 5-10 mg/kg/week; target 1000-2000 mg/day; max 60 mg/kg/day",
            "contraindications": "Pregnancy (teratogenic); hepatic disease; mitochondrial disease; pancreatitis history",
            "monitoring": "LFTs, ammonia, CBC, platelets at baseline, then q3-6mo; weight gain, hair loss, tremor",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Phenytoin",
            "indication": "Focal or generalized",
            "dosing": "300-400 mg daily (extended release) or divided TID (immediate release); adjust by level",
            "contraindications": "Pregnancy (relative - fetal hydantoin syndrome); AV block",
            "monitoring": "Free phenytoin level (target 1-2 Œºg/mL); total level 10-20 Œºg/mL; CBC, LFTs; gingival hyperplasia, hirsutism",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Brivaracetam",
            "indication": "Alternative to levetiracetam",
            "dosing": "Start 50 mg PO BID; may increase to 100 mg BID; max 200 mg/day",
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Less behavioral side effects than levetiracetam; somnolence; Schedule C-V",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Zonisamide",
            "indication": "Adjunctive or monotherapy",
            "dosing": "Start 100 mg daily; increase by 100 mg every 2 weeks; target 300-400 mg daily; max 600 mg/day",
            "contraindications": "Sulfonamide allergy; kidney stones",
            "monitoring": "Kidney stones (carbonic anhydrase inhibitor); oligohidrosis (pediatric); metabolic acidosis",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Topiramate",
            "indication": "Adjunctive or monotherapy",
            "dosing": "Start 25 mg BID; increase by 50 mg/day weekly; target 200-400 mg/day in divided doses; max 400 mg/day",
            "contraindications": "Kidney stones; metabolic acidosis; glaucoma",
            "monitoring": "Cognitive impairment (\"dopamax\"); paresthesias; kidney stones; weight loss",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Clobazam",
            "indication": "Adjunctive therapy",
            "dosing": "Start 5-10 mg daily; increase by 5-10 mg weekly; max 40 mg/day in divided doses",
            "contraindications": "Severe hepatic impairment; sleep apnea (untreated)",
            "monitoring": "Sedation; tolerance may develop; CYP2C19 poor metabolizers need lower dose",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Perampanel",
            "indication": "Adjunctive for focal or GTCS",
            "dosing": "Start 2 mg qHS; increase by 2 mg weekly; target 8-12 mg qHS; max 12 mg/day",
            "contraindications": "None absolute",
            "monitoring": "Psychiatric effects (aggression, hostility); dizziness; take at bedtime; Schedule III",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Cenobamate",
            "indication": "Adjunctive for focal",
            "dosing": "Start 12.5 mg daily √ó 2 weeks; titrate slowly per package insert; target 200-400 mg daily",
            "contraindications": "Familial short QT syndrome",
            "monitoring": "Very slow titration required (DRESS risk); QT shortening; titration pack available",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Phenobarbital",
            "indication": "Refractory or resource-limited",
            "dosing": "Load 15-20 mg/kg IV; maintenance 1-3 mg/kg/day (60-180 mg/day); target level 15-40 Œºg/mL",
            "contraindications": "Porphyria; severe respiratory disease",
            "monitoring": "Sedation; cognitive effects; drug interactions (CYP inducer); level monitoring",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Acetaminophen",
            "indication": "Post-ictal headache",
            "dosing": "650-1000 mg PO/IV q6h PRN; max 3000 mg/day (2000 mg if liver disease)",
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if chronic use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Ibuprofen",
            "indication": "Post-ictal headache",
            "dosing": "400-600 mg PO q6-8h PRN; max 2400 mg/day",
            "contraindications": "Renal impairment; GI bleed; post-CABG",
            "monitoring": "Renal function if prolonged use",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Ondansetron",
            "indication": "Post-ictal nausea",
            "dosing": "4-8 mg IV/PO q8h PRN",
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc if multiple doses",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Lorazepam",
            "indication": "Post-ictal agitation (if severe)",
            "dosing": "0.5-2 mg IV/PO PRN; use with caution",
            "contraindications": "Respiratory depression; altered mental status",
            "monitoring": "RR, sedation level; avoid if post-ictal confusion resolving",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          },
          {
            "item": "Sertraline",
            "indication": "Depression/anxiety (chronic)",
            "dosing": "Start 50 mg daily; increase by 25-50 mg q1-2 weeks; max 200 mg daily",
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Suicidality monitoring weeks 1-4",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Escitalopram",
            "indication": "Depression/anxiety (chronic)",
            "dosing": "Start 10 mg daily; max 20 mg daily",
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "QTc if risk factors",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Melatonin",
            "indication": "Sleep disturbance",
            "dosing": "3-5 mg PO qHS",
            "contraindications": "None significant",
            "monitoring": "Well tolerated; may help with ASM-related sleep disruption",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Trazodone",
            "indication": "Insomnia",
            "dosing": "25-100 mg PO qHS",
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Orthostatic hypotension; priapism (rare)",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Add second ASM",
            "dosing": "Choose complementary mechanism; see maintenance options",
            "contraindications": "Per specific agent",
            "monitoring": "Per specific agent",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy surgery evaluation referral",
            "dosing": "For drug-resistant epilepsy (failed 2+ appropriately chosen ASMs)",
            "contraindications": "N/A",
            "monitoring": "N/A",
            "ED": "‚Äî",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "Vagus nerve stimulator (VNS)",
            "dosing": "For drug-resistant epilepsy not surgical candidates",
            "contraindications": "N/A",
            "monitoring": "Device checks",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "Dietary therapy (ketogenic diet, modified Atkins)",
            "dosing": "For drug-resistant epilepsy",
            "contraindications": "Fatty acid oxidation disorders; pyruvate carboxylase deficiency",
            "monitoring": "Metabolic panels; lipids; kidney function",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "EXT",
            "ICU": "‚Äî"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult",
            "indication": "All new onset seizures for evaluation and management",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Epilepsy specialist referral",
            "indication": "Diagnostic uncertainty, refractory seizures, surgical candidacy",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "EEG technologist/neurodiagnostics",
            "indication": "EEG scheduling; continuous EEG if indicated",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Neurosurgery consult",
            "indication": "Structural lesion requiring intervention (tumor, AVM, SDH)",
            "ED": "‚Äî",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "URGENT"
          },
          {
            "item": "Medical toxicology consult",
            "indication": "Suspected drug/toxin-induced seizure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          },
          {
            "item": "Infectious disease consult",
            "indication": "CNS infection confirmed or suspected",
            "ED": "‚Äî",
            "HOSP": "URGENT",
            "OPD": "‚Äî",
            "ICU": "URGENT"
          },
          {
            "item": "Oncology consult",
            "indication": "Brain tumor identified",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Psychiatry consult",
            "indication": "Depression, anxiety post-diagnosis; psychogenic non-epileptic spells suspected",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Social work consult",
            "indication": "Driving restrictions impact, employment concerns, insurance navigation",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Occupational therapy",
            "indication": "Work safety evaluation, activity modification",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Physical therapy",
            "indication": "If post-ictal weakness, falls, injury from seizure",
            "ED": "‚Äî",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Neuropsychology referral",
            "indication": "Cognitive complaints, pre-surgical evaluation",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Women's health/OB-GYN",
            "indication": "Contraception counseling (ASM interactions), pregnancy planning",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "ROUTINE",
            "ICU": "‚Äî"
          },
          {
            "item": "Epilepsy monitoring unit (EMU) admission",
            "indication": "Characterize seizure type, video-EEG monitoring, pre-surgical evaluation",
            "ED": "‚Äî",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "‚Äî"
          },
          {
            "item": "Driving evaluation/rehabilitation",
            "indication": "Return to driving assessment when eligible",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "EXT",
            "ICU": "‚Äî"
          }
        ],
        "Patient Instructions": [
          {
            "item": "**Return to ED immediately if:** recurrent seizure, prolonged seizure >5 minutes, head injury, persistent confusion, difficulty breathing, or status epilepticus",
            "ED": "‚úì",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Do NOT drive until cleared by neurology (driving restrictions per state guidelines; typically require seizure-free interval)",
            "ED": "‚úì",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Avoid operating heavy machinery, working at heights, or swimming alone",
            "ED": "‚úì",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Do not bathe alone; showers preferred over baths; keep bathroom door unlocked",
            "ED": "‚úì",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Inform employer if job involves safety-sensitive duties",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Take ASM exactly as prescribed; do NOT stop abruptly (risk of breakthrough seizures or status epilepticus)",
            "ED": "‚úì",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Avoid common seizure triggers: sleep deprivation, alcohol, illicit drugs, missed medications",
            "ED": "‚úì",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Keep a seizure diary: date, time, duration, description, triggers, post-ictal symptoms",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Wear medical identification (bracelet or necklace)",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Educate family/coworkers on seizure first aid: stay with person, protect head, do NOT put anything in mouth, time the seizure, call 911 if >5 minutes",
            "ED": "‚úì",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Follow up with neurology within 1-2 weeks of discharge",
            "ED": "‚úì",
            "HOSP": "‚úì",
            "OPD": "‚Äî",
            "ICU": "‚Äî"
          },
          {
            "item": "Bring list of all medications (including OTC and supplements) to all appointments - many interact with ASMs",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Women: discuss contraception with provider; some ASMs reduce efficacy of hormonal contraception",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Report side effects (mood changes, rash, dizziness, cognitive issues) promptly; do NOT stop medication without calling",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Avoid flashing/strobe lights if photosensitive seizures suspected",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Sleep hygiene: aim for 7-9 hours nightly; maintain regular sleep schedule",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Avoid alcohol (lowers seizure threshold; interacts with ASMs)",
            "ED": "‚úì",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Avoid illicit drugs (especially stimulants: cocaine, amphetamines)",
            "ED": "‚úì",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Stress management techniques",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Regular moderate exercise (not extreme sleep deprivation from overtraining)",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Medication adherence: use pill organizers, phone alarms, refill reminders",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Folic acid supplementation 1-4 mg daily for women of childbearing potential (especially if on enzyme-inducing ASMs)",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Bone health: vitamin D 1000-2000 IU daily; calcium as needed (enzyme-inducing ASMs affect bone density)",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Avoid known personal triggers (flashing lights, certain foods, stress, if identified)",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Home safety modifications: pad sharp furniture corners, avoid glass shower doors, use microwave instead of stovetop when alone",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Seizure alert devices or apps for those living alone (optional)",
            "ED": "‚Äî",
            "HOSP": "‚Äî",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          },
          {
            "item": "Smoking cessation (increases ASM metabolism; general health)",
            "ED": "‚Äî",
            "HOSP": "‚úì",
            "OPD": "‚úì",
            "ICU": "‚Äî"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Syncope (convulsive syncope)",
        "features": "Brief (<15 sec), triggered by standing/Valsalva/micturition, rapid recovery, no post-ictal confusion, possible prodrome (lightheaded, tunnel vision)",
        "tests": "ECG, orthostatic vitals, tilt table test, echocardiogram"
      },
      {
        "diagnosis": "Psychogenic non-epileptic spells (PNES)",
        "features": "Variable/atypical semiology, prolonged duration, preserved awareness with bilateral movements, eye closure, pelvic thrusting, no post-ictal confusion, psychiatric comorbidity",
        "tests": "Video-EEG capturing event; normal prolactin"
      },
      {
        "diagnosis": "Transient ischemic attack (TIA)",
        "features": "Negative symptoms (weakness, numbness), no LOC, no convulsive activity",
        "tests": "MRI DWI, vascular imaging"
      },
      {
        "diagnosis": "Migraine with aura",
        "features": "Gradual onset, spreading symptoms, headache follows, stereotyped",
        "tests": "Clinical history, normal EEG"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Diaphoresis, tremor, confusion, rapid glucose corrects symptoms",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Cardiac arrhythmia",
        "features": "Palpitations, sudden LOC without warning, rapid recovery",
        "tests": "ECG, Holter monitor, event recorder, EP study"
      },
      {
        "diagnosis": "Transient global amnesia",
        "features": "Isolated anterograde amnesia, repetitive questioning, no convulsive activity",
        "tests": "Clinical presentation (self-limited), MRI DWI (hippocampal)"
      },
      {
        "diagnosis": "Sleep disorders (parasomnias, cataplexy)",
        "features": "Occur from sleep, specific features (cataplexy with emotion)",
        "tests": "Sleep study, clinical history"
      },
      {
        "diagnosis": "Movement disorders (dystonia, tics)",
        "features": "Stereotyped, no LOC, suppressible (tics), may have sensory urge",
        "tests": "Clinical history, video"
      },
      {
        "diagnosis": "Drug intoxication/withdrawal",
        "features": "History of substance use, known withdrawal timeline",
        "tests": "Toxicology screen, history"
      },
      {
        "diagnosis": "Metabolic encephalopathy",
        "features": "Gradual onset, diffuse abnormality, asterixis, no discrete seizures",
        "tests": "Labs (ammonia, glucose, Na), EEG (diffuse slowing)"
      }
    ],
    "evidence": [
      {
        "recommendation": "ILAE 2017 seizure classification",
        "evidenceLevel": "Class I",
        "source": "Fisher RS et al. Epilepsia 2017"
      },
      {
        "recommendation": "ILAE 2014 practical definition of epilepsy",
        "evidenceLevel": "Class I",
        "source": "Fisher RS et al. Epilepsia 2014"
      },
      {
        "recommendation": "EEG within 24-48h increases yield",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Practice Parameter 2007"
      },
      {
        "recommendation": "MRI superior to CT for epilepsy evaluation",
        "evidenceLevel": "Class I, Level A",
        "source": "ILAE Commission Report 2019"
      },
      {
        "recommendation": "Levetiracetam non-inferior to phenytoin for acute seizure cessation",
        "evidenceLevel": "Class I, Level A",
        "source": "ESETT Trial, NEJM 2019"
      },
      {
        "recommendation": "Risk of recurrence after first unprovoked seizure ~40-50%",
        "evidenceLevel": "Class I",
        "source": "Hauser et al., NEJM 1998"
      },
      {
        "recommendation": "Starting ASM after first seizure reduces recurrence but not long-term remission",
        "evidenceLevel": "Class I, Level A",
        "source": "FIRST and MESS trials"
      },
      {
        "recommendation": "Lamotrigine and levetiracetam preferred in women of childbearing potential",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN/AES Guidelines 2009, MONEAD Study"
      },
      {
        "recommendation": "Driving restrictions reduce accident risk",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple observational studies"
      },
      {
        "recommendation": "Prolactin elevation supports diagnosis of epileptic seizure (if drawn <20 min)",
        "evidenceLevel": "Class II, Level B",
        "source": "Chen et al., Neurology 2005"
      },
      {
        "recommendation": "Continuous EEG detects non-convulsive status in altered patients",
        "evidenceLevel": "Class II, Level B",
        "source": "Claassen et al., Neurology 2004"
      },
      {
        "recommendation": "Folate supplementation reduces teratogenicity risk",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Practice Parameter"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic exam (level of consciousness, focal deficits)",
        "frequency": "Q1-2h in ED; Q4h inpatient; each visit OPD",
        "action": "If prolonged post-ictal state: continuous EEG to rule out non-convulsive status",
        "ED": "‚úì",
        "HOSP": "‚úì",
        "OPD": "‚úì",
        "ICU": "‚úì"
      },
      {
        "item": "Vital signs",
        "frequency": "Continuous in ED/ICU; Q4h floor",
        "action": "Treat hyperthermia, hypotension, hypoxia",
        "ED": "‚úì",
        "HOSP": "‚úì",
        "OPD": "‚Äî",
        "ICU": "‚úì"
      },
      {
        "item": "Respiratory monitoring (post-benzodiazepine)",
        "frequency": "RR q15min √ó 1h post-administration; SpO2 continuous",
        "action": "Supplemental O2; airway management; consider flumazenil only if severe",
        "ED": "‚úì",
        "HOSP": "‚úì",
        "OPD": "‚Äî",
        "ICU": "‚úì"
      },
      {
        "item": "Glucose",
        "frequency": "On arrival; repeat if altered",
        "action": "Dextrose if low",
        "ED": "‚úì",
        "HOSP": "‚úì",
        "OPD": "‚Äî",
        "ICU": "‚úì"
      },
      {
        "item": "Electrolytes (Na, Ca, Mg)",
        "frequency": "On arrival; daily if abnormal",
        "action": "Correct deficiencies; identify cause",
        "ED": "‚úì",
        "HOSP": "‚úì",
        "OPD": "‚úì",
        "ICU": "‚úì"
      },
      {
        "item": "ASM level (phenytoin, valproate, phenobarbital, carbamazepine)",
        "frequency": "Trough level 5-7 days after initiation or dose change; PRN",
        "action": "Adjust dose; check free level for phenytoin",
        "ED": "‚Äî",
        "HOSP": "‚úì",
        "OPD": "‚úì",
        "ICU": "‚úì"
      },
      {
        "item": "LFTs",
        "frequency": "Baseline; q3-6 months on valproate, carbamazepine",
        "action": "Discontinue if hepatotoxicity; hold if transaminases >3√ó ULN",
        "ED": "‚Äî",
        "HOSP": "‚úì",
        "OPD": "‚úì",
        "ICU": "‚úì"
      },
      {
        "item": "CBC",
        "frequency": "Baseline; q3-6 months on carbamazepine, valproate",
        "action": "Discontinue if significant bone marrow suppression",
        "ED": "‚Äî",
        "HOSP": "‚úì",
        "OPD": "‚úì",
        "ICU": "‚úì"
      },
      {
        "item": "Sodium",
        "frequency": "Baseline; periodically on oxcarbazepine, carbamazepine",
        "action": "Reduce dose or switch if severe hyponatremia",
        "ED": "‚Äî",
        "HOSP": "‚úì",
        "OPD": "‚úì",
        "ICU": "‚úì"
      },
      {
        "item": "EEG",
        "frequency": "Within 24-48h of first seizure; repeat if diagnosis unclear",
        "action": "Adjust treatment if epileptiform activity or non-convulsive seizures",
        "ED": "‚úì",
        "HOSP": "‚úì",
        "OPD": "‚úì",
        "ICU": "‚úì"
      },
      {
        "item": "MRI brain",
        "frequency": "Within 2 weeks of first seizure; sooner if structural cause suspected",
        "action": "Address structural cause; refer to appropriate specialist",
        "ED": "‚Äî",
        "HOSP": "‚úì",
        "OPD": "‚úì",
        "ICU": "‚Äî"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Single, self-limited seizure; returned to baseline; no dangerous etiology identified on initial workup; reliable adult supervision for 24h; ASM initiated or deferred with close follow-up; outpatient EEG and MRI arranged; understands return precautions and driving restriction"
      },
      {
        "disposition": "**Admit to floor (observation)**",
        "criteria": "Prolonged post-ictal period; multiple seizures; new structural lesion requiring monitoring; ASM loading requiring observation; social situation preventing safe discharge; need for inpatient EEG; new focal neurologic deficit"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Status epilepticus (current or recent); recurrent seizures despite treatment; need for continuous EEG monitoring; airway compromise; hemodynamic instability; significant aspiration; large structural lesion with mass effect; CNS infection"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "MRI unavailable; EEG unavailable; neurology not available for consultation; need for neurosurgical intervention unavailable at facility"
      }
    ]
  },
  "Peripheral Neuropathy": {
    "version": "1.2",
    "icd10": "G62.9, G60.9, G62.0, G62.1, G63",
    "scope": "Initial diagnostic workup and symptomatic management of suspected or newly diagnosed peripheral neuropathy",
    "sections": {
      "Laboratory Workup": {
        "Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Anemia (B12), infection, malignancy screen"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Renal dysfunction (uremic neuropathy), hepatic disease"
          },
          {
            "item": "Fasting glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Diabetes screening"
          },
          {
            "item": "HbA1c",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Diabetes/prediabetes (most common cause)"
          },
          {
            "item": "Vitamin B12",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "B12 deficiency neuropathy"
          },
          {
            "item": "Methylmalonic acid (MMA)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If B12 borderline (200-400); more sensitive"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Hypothyroidism causes neuropathy"
          },
          {
            "item": "ESR",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory/vasculitic process"
          },
          {
            "item": "CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker"
          }
        ],
        "Extended Workup": [
          {
            "item": "Oral glucose tolerance test (2-hour)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Detects IGT missed by FBG/HbA1c; high yield in idiopathic neuropathy"
          },
          {
            "item": "SPEP with immunofixation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Monoclonal gammopathy (MGUS, myeloma)"
          },
          {
            "item": "Free light chains (kappa/lambda)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "AL amyloidosis, light chain deposition"
          },
          {
            "item": "Vitamin B1 (thiamine)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Alcoholism, malnutrition, bariatric surgery"
          },
          {
            "item": "Vitamin B6 (pyridoxine)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency OR toxicity (>200 mg/day) causes neuropathy"
          },
          {
            "item": "HIV antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated distal sensory polyneuropathy"
          },
          {
            "item": "Hepatitis B and C",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HBV-associated PAN, HCV cryoglobulinemia"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Connective tissue disease screen"
          },
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Sj√∂gren syndrome (small fiber)"
          }
        ],
        "Specialized": [
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If motor-predominant or acute onset (GBS variants)"
          },
          {
            "item": "Paraneoplastic panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Subacute sensory neuronopathy, weight loss, smoking"
          },
          {
            "item": "Genetic testing (CMT panel, TTR gene)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Hereditary neuropathy, familial amyloidosis"
          },
          {
            "item": "Skin punch biopsy for IENFD",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Small fiber neuropathy confirmation"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential": [
          {
            "item": "NCS/EMG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pattern determines axonal vs demyelinating, distribution, severity"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine (cervical/lumbar) with contrast",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "If radiculopathy, myelopathy, or polyradiculopathy suspected"
          },
          {
            "item": "MRI lumbar plexus with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lumbosacral plexopathy, asymmetric proximal weakness"
          },
          {
            "item": "Autonomic function testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Autonomic symptoms (orthostasis, anhidrosis, GI dysmotility)"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Lung cancer (paraneoplastic), sarcoidosis"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Rule out elevated ICP"
          },
          {
            "item": "Cell count",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammation, infection"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Albuminocytologic dissociation in GBS/CIDP"
          },
          {
            "item": "Glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Infection, carcinomatous meningitis"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Leptomeningeal carcinomatosis"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Thiamine IV (if alcoholic or malnourished)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "500 mg IV TID √ó 3 days, then 250 mg IV daily √ó 3-5 days",
            "rationale": "Correct thiamine deficiency"
          },
          {
            "item": "Vitamin B12 IM (if deficient)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "dosing": "1000 mcg IM daily √ó 7 days, then weekly √ó 4 weeks, then monthly",
            "rationale": "B12 replacement"
          },
          {
            "item": "Glucose control optimization",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "dosing": "Per diabetes protocol; target HbA1c <7%",
            "rationale": "Most important modifiable factor"
          }
        ],
        "Neuropathic Pain - First-Line": [
          {
            "item": "Gabapentin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": "Start 300 mg qHS; target 900-1800 mg TID; max 3600 mg/day; adjust for renal function",
            "rationale": "First-line for neuropathic pain"
          },
          {
            "item": "Pregabalin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": "Start 75 mg BID; max 300 mg BID; adjust for renal function",
            "rationale": "First-line; Schedule V controlled"
          },
          {
            "item": "Duloxetine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 30 mg daily √ó 1 week; increase to 60 mg; max 120 mg/day",
            "rationale": "First-line SNRI, especially for diabetic neuropathy"
          }
        ],
        "Neuropathic Pain - Second-Line": [
          {
            "item": "Amitriptyline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 10-25 mg qHS; max 150 mg qHS; ECG if >100 mg/day",
            "rationale": "Second-line; avoid in elderly (anticholinergic)"
          },
          {
            "item": "Nortriptyline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 10-25 mg qHS; max 150 mg qHS",
            "rationale": "Fewer anticholinergic effects than amitriptyline"
          },
          {
            "item": "Venlafaxine XR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 37.5-75 mg daily; max 225 mg daily",
            "rationale": "Alternative SNRI"
          },
          {
            "item": "Carbamazepine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 100 mg BID; max 1200 mg/day; HLA-B*1502 screening",
            "rationale": "For trigeminal neuralgia, lancinating pain"
          }
        ],
        "Topical Treatments": [
          {
            "item": "Lidocaine 5% patch",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": "Apply 1-3 patches for 12 hours on, 12 hours off",
            "rationale": "Localized neuropathic pain"
          },
          {
            "item": "Capsaicin cream 0.025-0.075%",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Apply TID-QID; takes 2-4 weeks for effect",
            "rationale": "Initial burning decreases with use"
          },
          {
            "item": "Capsaicin 8% patch (Qutenza)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Applied by healthcare provider for 30-60 minutes; repeat every 3 months",
            "rationale": "For refractory localized pain"
          }
        ],
        "Autonomic Dysfunction": [
          {
            "item": "Midodrine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": "Start 2.5 mg TID; max 10 mg TID; avoid within 4h of bedtime",
            "rationale": "Orthostatic hypotension"
          },
          {
            "item": "Fludrocortisone",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": "Start 0.1 mg daily; max 0.3 mg daily",
            "rationale": "Orthostatic hypotension; monitor K+"
          },
          {
            "item": "Droxidopa (Northera)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 100 mg TID; max 600 mg TID",
            "rationale": "Neurogenic orthostatic hypotension"
          }
        ],
        "Disease-Specific": [
          {
            "item": "IVIG",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "dosing": "2 g/kg over 2-5 days (induction); maintenance 0.4-1 g/kg every 2-4 weeks",
            "rationale": "CIDP, MMN, GBS"
          },
          {
            "item": "Plasma exchange (PLEX)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "dosing": "5-7 exchanges over 10-14 days",
            "rationale": "CIDP, GBS"
          },
          {
            "item": "Prednisone",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "1 mg/kg/day (max 80 mg) √ó 4-6 weeks; taper over 3-6 months",
            "rationale": "CIDP, vasculitic neuropathy"
          }
        ]
      },
      "Referrals & Consults": {
        "Consults": [
          {
            "item": "Neuromuscular neurology referral",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "All new neuropathy diagnoses for etiology workup"
          },
          {
            "item": "EMG referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "NCS/EMG for characterization"
          },
          {
            "item": "Physical therapy consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Balance and gait, falls prevention"
          },
          {
            "item": "Podiatry referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetic neuropathy, foot care, orthotics"
          },
          {
            "item": "Endocrinology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes management optimization"
          },
          {
            "item": "Pain management referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Refractory neuropathic pain, spinal cord stimulator evaluation"
          },
          {
            "item": "Hematology/Oncology referral",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Paraproteinemic neuropathy, suspected malignancy, amyloidosis"
          },
          {
            "item": "Genetic counseling referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Suspected hereditary neuropathy (CMT, hATTR)"
          }
        ]
      },
      "Patient Instructions": {
        "Safety & Foot Care": [
          {
            "item": "Return precautions: sudden severe weakness, difficulty breathing, rapid progression",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Know when to seek emergency care"
          },
          {
            "item": "Inspect feet daily for cuts, blisters, or wounds",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Early wound detection"
          },
          {
            "item": "Wear well-fitting, protective footwear at all times",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Never barefoot"
          },
          {
            "item": "Test bath water temperature before entering",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Avoid burns due to impaired sensation"
          },
          {
            "item": "Use night lights and handrails to prevent falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Fall prevention"
          },
          {
            "item": "Do not stop gabapentin/pregabalin abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Taper under medical guidance"
          }
        ],
        "Lifestyle": [
          {
            "item": "Strict glycemic control (HbA1c <7%)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Most important modifiable factor"
          },
          {
            "item": "Complete alcohol cessation",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Alcoholic neuropathy is reversible if early"
          },
          {
            "item": "Smoking cessation",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Microvascular disease worsens neuropathy"
          },
          {
            "item": "Regular exercise as tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Improves circulation, glycemic control, reduces pain"
          },
          {
            "item": "B12 supplementation if on metformin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Metformin depletes B12"
          },
          {
            "item": "Avoid excessive vitamin B6 (>100 mg/day)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "B6 toxicity causes neuropathy"
          }
        ]
      }
    }
  },
  "Multiple Sclerosis - New Diagnosis": {
    "id": "ms-new-diagnosis",
    "title": "Multiple Sclerosis - New Diagnosis",
    "version": "2.5",
    "icd10": [
      "** G35 (Multiple sclerosis)",
      "H46.9 (Optic neuritis",
      "if presenting symptom)",
      "G37.9 (Demyelinating disease of CNS",
      "unspecified)"
    ],
    "scope": "** Initial diagnostic workup and management of suspected or newly confirmed MS. Covers diagnostic criteria evaluation, mimics exclusion, acute symptom treatment, and DMT initiation framework. For established MS with acute relapse, use \"MS - Exacerbation\" template. For ongoing DMT management and monitoring, use \"MS - Maintenance\" template.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection screen, baseline before steroids",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Metabolic screen, renal function",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Thyroid disease mimics MS",
            "target": "Normal"
          },
          {
            "item": "Vitamin B12",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "B12 deficiency causes myelopathy",
            "target": "Normal (>300 pg/mL)"
          },
          {
            "item": "Folate",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Folate deficiency causes myelopathy",
            "target": "Normal"
          },
          {
            "item": "ESR",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory/vasculitis screen",
            "target": "Normal (<20 mm/hr)"
          },
          {
            "item": "CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker",
            "target": "Normal"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI as symptom trigger",
            "target": "Negative"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Pre-steroid baseline",
            "target": "Normal"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Glycemic status before steroids",
            "target": "<5.7%"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin D (25-OH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Low levels associated with MS risk/activity",
            "target": ">30 ng/mL"
          },
          {
            "item": "ANA",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Lupus/connective tissue disease screen",
            "target": "Negative or low titer"
          },
          {
            "item": "Anti-dsDNA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If ANA positive, lupus evaluation",
            "target": "Negative"
          },
          {
            "item": "**Mayo CDS1 Panel** (AQP4-IgG + MOG-IgG by FACS)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Combined NMO/MOGAD screen; cell-based assay is gold standard",
            "target": "Both negative"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated myelopathy/encephalopathy",
            "target": "Negative"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis mimics MS",
            "target": "Negative"
          },
          {
            "item": "Lyme serology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Endemic areas; neuroborreliosis",
            "target": "Negative"
          },
          {
            "item": "ACE level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosarcoidosis",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sj√É¬∂gren syndrome",
            "target": "Negative"
          },
          {
            "item": "ANCA panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "CNS vasculitis",
            "target": "Negative"
          },
          {
            "item": "Copper, ceruloplasmin",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal"
          },
          {
            "item": "Very long chain fatty acids",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Adrenomyeloneuropathy",
            "target": "Normal"
          },
          {
            "item": "Mitochondrial DNA studies",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Leber hereditary optic neuropathy",
            "target": "Normal"
          },
          {
            "item": "Genetic testing (HLA-DRB1)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Research/prognostic, not diagnostic",
            "target": "Variable"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast (MS protocol)*",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24-48h if acute; within 2 weeks if stable",
            "target": "Periventricular, juxtacortical, infratentorial, or cord lesions; gadolinium enhancement = active",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          },
          {
            "item": "MRI C-spine with and without contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "With brain MRI",
            "target": "Cord lesions (short segment, peripheral, dorsal)",
            "contraindications": "Same as above"
          },
          {
            "item": "MRI T-spine with and without contrast",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "With brain/C-spine",
            "target": "Cord lesions",
            "contraindications": "Same as above"
          }
        ],
        "Extended": [
          {
            "item": "Visual evoked potentials (VEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "During workup",
            "target": "Prolonged P100 latency (subclinical optic nerve involvement)",
            "contraindications": "None significant"
          },
          {
            "item": "OCT (Optical coherence tomography)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline",
            "target": "RNFL thinning (prior optic neuritis)",
            "contraindications": "None significant"
          },
          {
            "item": "MRI orbits with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If optic neuritis suspected",
            "target": "Optic nerve enhancement, swelling",
            "contraindications": "Gadolinium contraindications"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT chest",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If sarcoidosis suspected",
            "target": "Hilar lymphadenopathy",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "PET-CT",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS lymphoma or paraneoplastic suspected",
            "target": "FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes"
          },
          {
            "item": "Conventional angiography",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS vasculitis suspected",
            "target": "Beading, stenosis",
            "contraindications": "Contrast allergy, renal failure"
          },
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Atypical cases, tumefactive lesions",
            "target": "Demyelination vs neoplasm vs other",
            "contraindications": "Coagulopathy, inaccessible location"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Inflammation, rule out infection",
            "target": "WBC <50 (mild pleocytosis acceptable); RBC 0"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in inflammation",
            "target": "Normal to mildly elevated (<100 mg/dL)"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Low in infection/carcinomatous",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out infection",
            "target": "No organisms"
          },
          {
            "item": "Oligoclonal bands (CSF AND serum)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal IgG synthesis",
            "target": "√¢‚Ä∞¬•2 CSF-specific bands (not in serum)"
          },
          {
            "item": "IgG index",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody synthesis",
            "target": ">0.7 = elevated"
          },
          {
            "item": "Myelin basic protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Active demyelination marker",
            "target": "May be elevated acutely"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out malignancy",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Methylprednisolone IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "1000 mg IV daily √É‚Äî 3-5 days",
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose q6h (target <180), BP, mood, sleep, I/O"
          },
          {
            "item": "Omeprazole",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "20-40 mg daily during steroids",
            "contraindications": "PPI allergy",
            "monitoring": "None routine"
          },
          {
            "item": "Insulin sliding scale",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": "Per protocol if glucose >180 mg/dL",
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose q6h"
          },
          {
            "item": "Prednisone oral taper (optional)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "60 mg daily √É‚Äî 7 days, then taper over 2 weeks",
            "contraindications": "Same as IV steroids",
            "monitoring": "Glucose, BP, mood"
          }
        ],
        "Symptomatic Treatments - First-line": [
          {
            "item": "Baclofen",
            "indication": "Spasticity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": "Start 5 mg TID; increase by 5 mg/dose every 3 days; max 80 mg/day in divided doses",
            "contraindications": "Renal impairment (reduce dose)",
            "monitoring": "Sedation, weakness; do NOT stop abruptly (withdrawal risk)"
          },
          {
            "item": "Tizanidine",
            "indication": "Spasticity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": "Start 2 mg qHS or TID; increase by 2-4 mg every 3-4 days; max 36 mg/day in 3 divided doses",
            "contraindications": "Hepatic impairment; concurrent ciprofloxacin or fluvoxamine (CYP1A2 inhibitors)",
            "monitoring": "LFTs at baseline, 1, 3, 6 months; sedation; hypotension"
          },
          {
            "item": "Gabapentin",
            "indication": "Neuropathic pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": "Start 300 mg qHS; increase by 300 mg every 1-3 days; target 900-1800 mg TID; max 3600 mg/day",
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Sedation, dizziness, peripheral edema"
          },
          {
            "item": "Pregabalin",
            "indication": "Neuropathic pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID",
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Sedation, weight gain, peripheral edema"
          },
          {
            "item": "Duloxetine",
            "indication": "Neuropathic pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 30 mg daily √É‚Äî 1 week; increase to 60 mg daily; max 120 mg/day",
            "contraindications": "Hepatic impairment; concurrent MAOIs; uncontrolled narrow-angle glaucoma",
            "monitoring": "Nausea (usually transient), BP, discontinuation syndrome"
          },
          {
            "item": "Amitriptyline",
            "indication": "Neuropathic pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; narrow-angle glaucoma",
            "monitoring": "Anticholinergic effects; ECG if dose >100 mg/day"
          },
          {
            "item": "Carbamazepine",
            "indication": "Trigeminal neuralgia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 100 mg BID; increase by 200 mg/day every 3-7 days; max 1200 mg/day",
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening in at-risk populations"
          },
          {
            "item": "Oxcarbazepine",
            "indication": "Trigeminal neuralgia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 300 mg BID; increase by 300 mg every 3 days; max 1200 mg BID",
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia risk); HLA-B*1502 screening"
          },
          {
            "item": "Oxybutynin IR",
            "indication": "Bladder urgency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 5 mg BID-TID; max 5 mg QID",
            "contraindications": "Urinary retention; uncontrolled narrow-angle glaucoma; GI obstruction",
            "monitoring": "Dry mouth, constipation, cognitive impairment (especially elderly)"
          },
          {
            "item": "Oxybutynin ER",
            "indication": "Bladder urgency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 5-10 mg daily; max 30 mg daily",
            "contraindications": "Same as IR",
            "monitoring": "Same; fewer anticholinergic side effects than IR"
          },
          {
            "item": "Solifenacin",
            "indication": "Bladder urgency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 5 mg daily; may increase to 10 mg daily",
            "contraindications": "Urinary retention; gastric retention; uncontrolled narrow-angle glaucoma; severe hepatic impairment",
            "monitoring": "Dry mouth, constipation; preferred over oxybutynin if cognitive concerns"
          },
          {
            "item": "Mirabegron",
            "indication": "Bladder urgency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 25 mg daily; may increase to 50 mg daily",
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP monitoring; fewer anticholinergic effects (beta-3 agonist)"
          },
          {
            "item": "Tamsulosin",
            "indication": "Urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "0.4 mg daily 30 minutes after same meal each day",
            "contraindications": "Severe sulfonamide allergy (use caution)",
            "monitoring": "Orthostatic hypotension; retrograde ejaculation"
          },
          {
            "item": "Bethanechol",
            "indication": "Urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "10-50 mg TID-QID",
            "contraindications": "Asthma; bradycardia; hypotension; GI/GU obstruction",
            "monitoring": "GI cramping, bronchospasm"
          },
          {
            "item": "Desmopressin",
            "indication": "Nocturia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "0.1-0.4 mg qHS (oral) or 10-40 mcg intranasal",
            "contraindications": "Hyponatremia risk; age >65 (relative); CHF; polydipsia",
            "monitoring": "Sodium at baseline, 1 week, 1 month, then periodically; fluid restrict evening"
          },
          {
            "item": "Amantadine",
            "indication": "Fatigue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "100 mg every morning; may add 100 mg early afternoon (before 2 PM); max 200 mg/day",
            "contraindications": "Renal impairment (adjust dose); uncontrolled seizures",
            "monitoring": "Livedo reticularis; ankle edema; insomnia; hallucinations"
          },
          {
            "item": "Modafinil",
            "indication": "Fatigue",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 100 mg every morning; may increase to 200 mg; max 400 mg/day",
            "contraindications": "Cardiac arrhythmia; LV hypertrophy; hepatic impairment",
            "monitoring": "BP, HR; may reduce efficacy of hormonal contraception; Schedule IV"
          },
          {
            "item": "Armodafinil",
            "indication": "Fatigue",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 150 mg every morning; max 250 mg daily",
            "contraindications": "Same as modafinil",
            "monitoring": "Same as modafinil; longer half-life; Schedule IV"
          },
          {
            "item": "Methylphenidate",
            "indication": "Fatigue",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 5 mg BID (morning and noon); max 60 mg/day",
            "contraindications": "Marked anxiety; glaucoma; tics/Tourette; concurrent MAOIs",
            "monitoring": "BP, HR, mood; Schedule II"
          },
          {
            "item": "Dalfampridine",
            "indication": "Walking impairment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "10 mg q12h (must be exactly 12 hours apart); do NOT exceed 20 mg/day",
            "contraindications": "Seizure history; CrCl <50 mL/min",
            "monitoring": "Seizure risk (dose-dependent); UTI; insomnia"
          },
          {
            "item": "Sertraline",
            "indication": "Depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 50 mg daily; increase by 25-50 mg every 1-2 weeks; max 200 mg daily",
            "contraindications": "Concurrent MAOIs; pimozide",
            "monitoring": "Suicidality monitoring (especially weeks 1-4); serotonin syndrome; QTc at high doses"
          },
          {
            "item": "Escitalopram",
            "indication": "Depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 10 mg daily; may increase to 20 mg after 1 week; max 20 mg daily",
            "contraindications": "Concurrent MAOIs; pimozide; QT prolongation",
            "monitoring": "QTc if risk factors or dose >10 mg; suicidality monitoring"
          },
          {
            "item": "Fluoxetine",
            "indication": "Depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 20 mg daily; may increase after several weeks; max 80 mg daily",
            "contraindications": "Concurrent MAOIs; pimozide; thioridazine",
            "monitoring": "Long half-life (washout important); suicidality monitoring"
          },
          {
            "item": "Bupropion SR/XL",
            "indication": "Depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 150 mg SR daily; increase to 150 mg SR BID after 3 days (or 300 mg XL daily); max 400 mg/day",
            "contraindications": "Seizure disorder; eating disorders; abrupt alcohol/benzo withdrawal",
            "monitoring": "Seizure risk; insomnia; no sexual side effects"
          },
          {
            "item": "Venlafaxine XR",
            "indication": "Depression/pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 37.5-75 mg daily; increase by 75 mg every 4 days; max 225 mg daily",
            "contraindications": "Uncontrolled hypertension; concurrent MAOIs",
            "monitoring": "BP monitoring; discontinuation syndrome (taper slowly)"
          },
          {
            "item": "Mirtazapine",
            "indication": "Depression/insomnia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 15 mg qHS; may increase by 15 mg every 1-2 weeks; max 45 mg daily",
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Weight gain; sedation (lower at higher doses); agranulocytosis (rare)"
          },
          {
            "item": "Polyethylene glycol 3350",
            "indication": "Constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "17 g (1 capful) in 8 oz liquid once daily; adjust to effect",
            "contraindications": "Bowel obstruction; ileus",
            "monitoring": "Electrolytes if prolonged use; may take 1-3 days for effect"
          },
          {
            "item": "Docusate sodium",
            "indication": "Constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "100 mg BID; max 500 mg/day",
            "contraindications": "Intestinal obstruction; concurrent mineral oil",
            "monitoring": "Minimal efficacy as monotherapy; best for stool softening"
          },
          {
            "item": "Senna",
            "indication": "Constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "8.6-17.2 mg qHS; max 34.4 mg/day",
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping; dependency with chronic daily use"
          },
          {
            "item": "Bisacodyl",
            "indication": "Constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "5-10 mg PO qHS or 10 mg PR PRN",
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping; electrolyte disturbance with overuse"
          },
          {
            "item": "Lubiprostone",
            "indication": "Constipation (refractory)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "24 mcg BID with food",
            "contraindications": "Mechanical GI obstruction",
            "monitoring": "Nausea (common); dyspnea; diarrhea"
          },
          {
            "item": "Propranolol",
            "indication": "Tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 20 mg BID; increase by 20-40 mg every 3-7 days; max 320 mg/day in divided doses",
            "contraindications": "Asthma/COPD; bradycardia <50; heart block; decompensated CHF",
            "monitoring": "HR, BP; fatigue; depression; bronchospasm"
          },
          {
            "item": "Primidone",
            "indication": "Tremor",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 25 mg qHS; increase by 25 mg every week to 250 mg TID; usual dose 50-250 mg TID",
            "contraindications": "Porphyria; hypersensitivity to phenobarbital",
            "monitoring": "Severe sedation initially (start very low); ataxia; nausea"
          },
          {
            "item": "Clonazepam",
            "indication": "Tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 0.25-0.5 mg BID; increase by 0.5 mg every 3 days; max 6 mg/day",
            "contraindications": "Severe hepatic impairment; myasthenia gravis; untreated narrow-angle glaucoma",
            "monitoring": "Sedation; dependence; falls risk; do NOT stop abruptly"
          },
          {
            "item": "Topiramate",
            "indication": "Tremor",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Start 25 mg daily; increase by 25 mg weekly; max 400 mg/day in divided doses",
            "contraindications": "Metabolic acidosis; kidney stones",
            "monitoring": "Cognitive slowing (\"dopamax\"); paresthesias; kidney stones; weight loss"
          },
          {
            "item": "Dextromethorphan-quinidine",
            "indication": "Pseudobulbar affect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "20/10 mg daily √É‚Äî 7 days, then 20/10 mg q12h",
            "contraindications": "QT prolongation; concurrent MAOIs; concurrent quinidine/quinine; CYP2D6 substrate drugs",
            "monitoring": "ECG at baseline; QTc monitoring; multiple drug interactions"
          }
        ],
        "Second-line/Refractory (Acute Treatment)": [
          {
            "item": "Plasmapheresis (PLEX)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "dosing": "5-7 exchanges over 10-14 days",
            "contraindications": "Hemodynamic instability, sepsis, line contraindication",
            "monitoring": "BP, electrolytes, coags, fibrinogen, line infection"
          },
          {
            "item": "IVIG",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "dosing": "0.4 g/kg/day √É‚Äî 5 days",
            "contraindications": "IgA deficiency, renal failure, thrombosis risk",
            "monitoring": "Renal function, headache, thrombosis"
          },
          {
            "item": "Extended IV steroids",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "dosing": "Additional 2-5 days methylprednisolone (total 5-10 days)",
            "contraindications": "As above",
            "monitoring": "As above"
          },
          {
            "item": "ACTH gel (H.P. Acthar)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "dosing": "80 units IM/SC daily √É‚Äî 2-3 weeks",
            "contraindications": "Similar to corticosteroids",
            "monitoring": "Glucose, BP, electrolytes"
          }
        ],
        "Disease-Modifying Therapies (DMT) - OPD ONLY": [
          {
            "item": "**INJECTABLE - MODERATE EFFICACY**"
          },
          {
            "item": "Interferon beta-1a (Avonex)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "30 mcg IM once weekly",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; flu-like symptoms common (pretreat with NSAIDs/acetaminophen)"
          },
          {
            "item": "Interferon beta-1a (Rebif)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "22 or 44 mcg SC three times weekly (titrate over 4 weeks)",
            "contraindications": "Same as Avonex",
            "monitoring": "Same; injection site reactions"
          },
          {
            "item": "Interferon beta-1b (Betaseron/Extavia)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "250 mcg SC every other day (titrate over 6 weeks)",
            "contraindications": "Same as Avonex",
            "monitoring": "Same"
          },
          {
            "item": "Peginterferon beta-1a (Plegridy)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "125 mcg SC every 14 days (titrate over first 4 doses)",
            "contraindications": "Same as Avonex",
            "monitoring": "Same; less frequent dosing"
          },
          {
            "item": "Glatiramer acetate (Copaxone) 20mg",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "20 mg SC daily",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions; post-injection systemic reaction (rare, self-limited)"
          },
          {
            "item": "Glatiramer acetate (Copaxone) 40mg",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "40 mg SC three times weekly (√¢‚Ä∞¬•48 hours apart)",
            "contraindications": "Hypersensitivity",
            "monitoring": "Same"
          },
          {
            "item": "Glatiramer acetate (Glatopa)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "20 mg SC daily or 40 mg SC three times weekly",
            "contraindications": "Hypersensitivity",
            "monitoring": "Same (generic)"
          },
          {
            "item": "**ORAL - MODERATE EFFICACY**"
          },
          {
            "item": "Dimethyl fumarate (Tecfidera)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "120 mg BID √É‚Äî 7 days, then 240 mg BID",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; GI side effects (take with food); flushing (aspirin 30 min prior)"
          },
          {
            "item": "Diroximel fumarate (Vumerity)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "231 mg BID √É‚Äî 7 days, then 462 mg BID",
            "contraindications": "Same as Tecfidera",
            "monitoring": "Same; less GI side effects than Tecfidera"
          },
          {
            "item": "Monomethyl fumarate (Bafiertam)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "95 mg BID √É‚Äî 7 days, then 190 mg BID",
            "contraindications": "Same as Tecfidera",
            "monitoring": "Same"
          },
          {
            "item": "Teriflunomide (Aubagio)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "7 or 14 mg once daily",
            "contraindications": "Pregnancy (Category X - teratogenic); severe hepatic impairment; concurrent leflunomide",
            "monitoring": "LFTs monthly √É‚Äî 6 months, then periodically; BP; hair thinning; requires cholestyramine washout if pregnancy desired"
          },
          {
            "item": "**ORAL - HIGH EFFICACY (S1P MODULATORS)**"
          },
          {
            "item": "Fingolimod (Gilenya)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "0.5 mg once daily",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA (within 6 months)",
            "monitoring": "First-dose observation 6 hours (HR, BP q1h, ECG at 6h); macular edema screen at 3-4 months; lymphocytes; LFTs"
          },
          {
            "item": "Siponimod (Mayzent)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Titration pack days 1-5, then 2 mg daily (1 mg if CYP2C9 *1/*3 or *2/*3)",
            "contraindications": "Same plus CYP2C9 *3/*3 genotype (contraindicated)",
            "monitoring": "Same; genotype required before starting"
          },
          {
            "item": "Ozanimod (Zeposia)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "0.23 mg daily √É‚Äî 4 days, 0.46 mg daily √É‚Äî 3 days, then 0.92 mg daily",
            "contraindications": "Same; concurrent MAOIs",
            "monitoring": "Similar to fingolimod; no first-dose observation required (slower titration); macular edema screen"
          },
          {
            "item": "Ponesimod (Ponvory)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "14-day titration pack, then 20 mg daily",
            "contraindications": "Same",
            "monitoring": "Similar; no first-dose observation required"
          },
          {
            "item": "**ORAL - HIGH EFFICACY (OTHER)**"
          },
          {
            "item": "Cladribine (Mavenclad)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Year 1: 1.75 mg/kg divided into 2 treatment weeks (week 1 and week 5); Year 2: repeat same dosing; no treatment years 3-4",
            "contraindications": "Active infection; HIV; active malignancy; pregnancy/breastfeeding; CrCl <30",
            "monitoring": "CBC at months 2 and 6 of each treatment year; lymphopenia expected and desired; screen for malignancy"
          },
          {
            "item": "**INFUSION - HIGH EFFICACY**"
          },
          {
            "item": "Natalizumab (Tysabri)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "300 mg IV every 4 weeks (or extended interval q6 weeks if stable and JCV negative)",
            "contraindications": "JCV antibody positive with index >1.5 and prior immunosuppression (high PML risk); active infection",
            "monitoring": "JCV antibody q6mo; MRI for PML surveillance q6-12mo; infusion reactions; REMS program required"
          },
          {
            "item": "Ocrelizumab (Ocrevus)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Initial: 300 mg IV √É‚Äî 2 doses 14 days apart; Maintenance: 600 mg IV every 6 months",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; infusion reactions (premedicate with methylprednisolone, antihistamine, acetaminophen)"
          },
          {
            "item": "Ofatumumab (Kesimpta)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Initial: 20 mg SC at weeks 0, 1, 2; Maintenance: 20 mg SC monthly starting week 4",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Same as ocrelizumab; self-administered at home"
          },
          {
            "item": "Ublituximab (Briumvi)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Initial: 150 mg IV day 1, 450 mg IV day 15; Maintenance: 450 mg IV every 24 weeks",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Same as ocrelizumab; 1-hour infusion (faster)"
          },
          {
            "item": "Alemtuzumab (Lemtrada)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "Year 1: 12 mg IV daily √É‚Äî 5 consecutive days; Year 2: 12 mg IV daily √É‚Äî 3 consecutive days (12 months after year 1)",
            "contraindications": "Active infection; HIV; ongoing autoimmune disease other than MS",
            "monitoring": "CBC monthly √É‚Äî 48 months; TSH q3mo √É‚Äî 48 months; creatinine/urinalysis monthly √É‚Äî 48 months; REMS program; secondary autoimmunity risk (thyroid, ITP, nephropathy)"
          },
          {
            "item": "**MODERATE EFFICACY - SPECIAL POPULATIONS**"
          },
          {
            "item": "Glatiramer acetate (Copaxone)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": "20 mg daily or 40 mg TIW",
            "contraindications": "Hypersensitivity",
            "monitoring": "Preferred in pregnancy (no evidence of harm)"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "MS specialist/Neuroimmunology referral",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "All new MS diagnoses for DMT discussion"
          },
          {
            "item": "Neuro-ophthalmology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Optic neuritis, visual symptoms, OCT baseline"
          },
          {
            "item": "Physical therapy consult for gait and balance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Gait dysfunction, lower extremity weakness, falls"
          },
          {
            "item": "Occupational therapy consult for ADL assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Upper extremity dysfunction, ADL impairment, energy conservation"
          },
          {
            "item": "Speech therapy for swallow evaluation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Brainstem involvement, dysphagia, dysarthria"
          },
          {
            "item": "Speech therapy for cognitive rehabilitation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive complaints affecting function"
          },
          {
            "item": "Urology referral for bladder dysfunction",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Urgency, frequency, retention, recurrent UTI"
          },
          {
            "item": "Psychiatry/Psychology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Depression, anxiety, adjustment to diagnosis"
          },
          {
            "item": "Social work consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Insurance navigation, disability questions, support resources"
          },
          {
            "item": "Rehabilitation medicine consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Significant functional impairment, comprehensive rehab needs"
          },
          {
            "item": "Infusion center coordination",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "PLEX scheduling; future DMT infusion planning"
          },
          {
            "item": "Ophthalmology referral (pre-DMT)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Baseline macular exam before S1P modulator initiation"
          },
          {
            "item": "Genetic counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "If atypical features, family history concerns"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if rapid vision loss, sudden weakness, difficulty breathing, or urinary retention",
            "ED": "√¢≈ì‚Äú",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Avoid driving until cleared by neurology",
            "ED": "√¢≈ì‚Äú",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Heat may temporarily worsen symptoms (Uhthoff phenomenon) - this is not a new attack",
            "ED": "√¢≈ì‚Äú",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Expect temporary steroid side effects: insomnia, mood changes, increased appetite, metallic taste",
            "ED": "√¢≈ì‚Äú",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "-"
          },
          {
            "item": "Keep symptom diary noting new or worsening symptoms",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Do not stop steroids abruptly if on oral taper",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Do not stop baclofen or tizanidine abruptly - risk of withdrawal/rebound spasticity",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Monitor blood sugars if diabetic - steroids elevate glucose",
            "ED": "√¢≈ì‚Äú",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Avoid sick contacts while on high-dose steroids",
            "ED": "√¢≈ì‚Äú",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "-"
          },
          {
            "item": "Contact MS specialist before starting any new medications (drug interactions with DMTs)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Vaccinations should be completed before DMT initiation (especially live vaccines)",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Pregnancy planning requires DMT discussion (some DMTs teratogenic, washout periods vary)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Report any signs of infection (fever, cough, dysuria) promptly",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Post-void residual check if difficulty emptying bladder or recurrent UTIs",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (smoking accelerates MS progression and disability)",
            "ED": "√¢≈ì‚Äú",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Vitamin D supplementation 2000-5000 IU daily (target serum 25-OH vitamin D >40 ng/mL)",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Regular aerobic exercise 150 min/week as tolerated (improves fatigue, mood, function)",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Resistance training 2-3√É‚Äî/week",
            "ED": "-",
            "HOSP": "-",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Stress management and adequate sleep (7-8 hours nightly)",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Avoid excessive heat exposure (hot tubs, saunas, prolonged direct sun, exercising in heat)",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Cooling vest for outdoor activities in warm weather",
            "ED": "-",
            "HOSP": "-",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Maintain healthy weight (obesity associated with worse outcomes)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Limit alcohol intake (can worsen balance, cognition, bladder symptoms)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Ensure vaccinations up to date before DMT initiation (live vaccines contraindicated on many DMTs)",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Fall prevention: remove loose rugs, ensure adequate lighting, use assistive devices if needed",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          },
          {
            "item": "Energy conservation techniques for fatigue management (pacing, prioritization, positioning)",
            "ED": "-",
            "HOSP": "√¢≈ì‚Äú",
            "OPD": "√¢≈ì‚Äú"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Neuromyelitis optica spectrum disorder (NMOSD)",
        "features": "Longitudinally extensive transverse myelitis (√¢‚Ä∞¬•3 segments), severe optic neuritis (often bilateral), area postrema syndrome (intractable nausea/vomiting), brain lesions in NMOSD-typical locations",
        "tests": "AQP4-IgG positive (Mayo CDS1 or NMOFS); MRI pattern different"
      },
      {
        "diagnosis": "MOG antibody disease (MOGAD)",
        "features": "Bilateral optic neuritis, ADEM-like presentation, longitudinally extensive myelitis, cortical encephalitis, better steroid response, more favorable prognosis",
        "tests": "MOG-IgG positive (Mayo CDS1 or MOGFS)"
      },
      {
        "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
        "features": "Monophasic (usually), encephalopathy, post-infectious, large poorly-defined lesions, pediatric predominance",
        "tests": "Clinical course, MRI pattern, MOG-IgG status"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Headache, encephalopathy, stroke-like episodes, multifocal infarcts",
        "tests": "Elevated ESR/CRP, angiography, brain/leptomeningeal biopsy"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Cranial neuropathies (especially VII), hypothalamic involvement, leptomeningeal enhancement, hilar adenopathy",
        "tests": "ACE level, chest CT, biopsy (non-caseating granulomas)"
      },
      {
        "diagnosis": "CNS lymphoma",
        "features": "Progressive course, deep gray matter/periventricular involvement, homogeneous enhancement, older/immunocompromised",
        "tests": "CSF cytology/flow, FDG-PET, biopsy"
      },
      {
        "diagnosis": "Susac syndrome",
        "features": "Encephalopathy, hearing loss, branch retinal artery occlusions, corpus callosum \"snowball\" lesions",
        "tests": "Audiogram, fluorescein angiography, MRI pattern"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "Progressive cognitive decline, tabes dorsalis, Argyll Robertson pupils, positive serology",
        "tests": "RPR/VDRL, CSF VDRL, FTA-ABS"
      },
      {
        "diagnosis": "HIV-associated myelopathy/encephalopathy",
        "features": "Risk factors, vacuolar myelopathy, cognitive impairment",
        "tests": "HIV testing, CD4 count"
      },
      {
        "diagnosis": "B12 deficiency myelopathy",
        "features": "Subacute combined degeneration, dorsal column signs, peripheral neuropathy, macrocytic anemia",
        "tests": "B12, MMA, homocysteine"
      },
      {
        "diagnosis": "Migraine with white matter lesions",
        "features": "Headache history, non-specific white matter changes, no enhancement, no cord lesions",
        "tests": "Clinical history, MRI pattern"
      },
      {
        "diagnosis": "Small vessel ischemic disease",
        "features": "Older age, vascular risk factors, periventricular caps/halos, no enhancement, no cord lesions",
        "tests": "Risk factor profile, MRI pattern"
      }
    ],
    "evidence": [
      {
        "recommendation": "2017 McDonald Criteria for MS diagnosis",
        "evidenceLevel": "Class I",
        "source": "[Thompson AJ et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29275977/)"
      },
      {
        "recommendation": "MRI brain/spine with contrast for diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wattjes MP et al. Lancet Neurol 2021 (MAGNIMS)](https://pubmed.ncbi.nlm.nih.gov/34139157/)"
      },
      {
        "recommendation": "CSF OCBs can substitute for dissemination in time",
        "evidenceLevel": "Class II, Level B",
        "source": "[Thompson AJ et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29275977/)"
      },
      {
        "recommendation": "IV methylprednisolone 1g √É‚Äî 3-5 days for acute attacks",
        "evidenceLevel": "Class I, Level A",
        "source": "[Filippini et al. Cochrane 2000](https://pubmed.ncbi.nlm.nih.gov/11034713/); Expert consensus"
      },
      {
        "recommendation": "PLEX for steroid-refractory attacks",
        "evidenceLevel": "Class II, Level B",
        "source": "[Faissner et al. J Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/27039388/)"
      },
      {
        "recommendation": "Cell-based assay (FACS) for NMO/MOG antibodies",
        "evidenceLevel": "Class I, Level B",
        "source": "[Waters et al. 2014](https://pubmed.ncbi.nlm.nih.gov/27840658/); [Pittock et al.](https://pmc.ncbi.nlm.nih.gov/articles/PMC3286228/)"
      },
      {
        "recommendation": "Vitamin D supplementation",
        "evidenceLevel": "Class II, Level B",
        "source": "[SOLAR trial](https://pubmed.ncbi.nlm.nih.gov/31594857/); [CHOLINE trial](https://pubmed.ncbi.nlm.nih.gov/31454777/)"
      },
      {
        "recommendation": "Smoking cessation reduces progression",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hedstr√∂m et al. Brain 2013](https://pubmed.ncbi.nlm.nih.gov/23365092/)"
      },
      {
        "recommendation": "Early DMT initiation improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[BENEFIT extension](https://pubmed.ncbi.nlm.nih.gov/26833940/); Multiple RCTs"
      },
      {
        "recommendation": "Dalfampridine for walking impairment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goodman et al. Lancet 2009](https://pubmed.ncbi.nlm.nih.gov/19249634/)"
      },
      {
        "recommendation": "Exercise improves fatigue and function",
        "evidenceLevel": "Class I, Level B",
        "source": "[Heine et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/26358158/)"
      }
    ],
    "monitoring": [
      {
        "item": "Blood glucose",
        "ED": "‚úì",
        "HOSP": "‚úì",
        "OPD": "-",
        "ICU": "‚úì",
        "frequency": "Q6h during IV steroids",
        "action": "Insulin sliding scale; endocrine consult if persistent >250"
      },
      {
        "item": "Blood pressure",
        "ED": "‚úì",
        "HOSP": "‚úì",
        "OPD": "-",
        "ICU": "‚úì",
        "frequency": "Q shift during steroids",
        "action": "Antihypertensives PRN"
      },
      {
        "item": "Mood and sleep",
        "ED": "-",
        "HOSP": "‚úì",
        "OPD": "-",
        "ICU": "‚úì",
        "frequency": "Daily during steroids",
        "action": "Psychiatry consult; consider dose adjustment"
      },
      {
        "item": "Temperature",
        "ED": "‚úì",
        "HOSP": "‚úì",
        "OPD": "-",
        "ICU": "‚úì",
        "frequency": "Q shift",
        "action": "Infection workup if febrile"
      },
      {
        "item": "Neurologic exam",
        "ED": "‚úì",
        "HOSP": "‚úì",
        "OPD": "‚úì",
        "ICU": "‚úì",
        "frequency": "Daily (inpatient); each visit (OPD)",
        "action": "If worsening: re-image, consider PLEX"
      },
      {
        "item": "I/O and weight",
        "ED": "-",
        "HOSP": "‚úì",
        "OPD": "-",
        "ICU": "‚úì",
        "frequency": "Daily (inpatient)",
        "action": "Diuretics if fluid overload"
      },
      {
        "item": "Respiratory status",
        "ED": "-",
        "HOSP": "‚úì",
        "OPD": "-",
        "ICU": "‚úì",
        "frequency": "Q shift if cervical myelitis",
        "action": "ICU transfer if NIF >-20 (critical)"
      },
      {
        "item": "Post-void residual",
        "ED": "-",
        "HOSP": "‚úì",
        "OPD": "‚úì",
        "ICU": "-",
        "frequency": "If retention suspected",
        "action": "Intermittent catheterization if >200 mL; urology referral"
      },
      {
        "item": "MRI (follow-up) - early",
        "ED": "-",
        "HOSP": "-",
        "OPD": "‚úì",
        "ICU": "-",
        "frequency": "3 months after baseline",
        "action": "DMT escalation discussion if new activity"
      },
      {
        "item": "MRI (follow-up) - standard",
        "ED": "-",
        "HOSP": "-",
        "OPD": "‚úì",
        "ICU": "-",
        "frequency": "6 months after baseline, then annually",
        "action": "DMT escalation discussion if new activity"
      },
      {
        "item": "Vitamin D level",
        "ED": "-",
        "HOSP": "-",
        "OPD": "‚úì",
        "ICU": "-",
        "frequency": "Annually",
        "action": "Increase supplementation if low"
      },
      {
        "item": "JCV antibody (if on natalizumab)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "‚úì",
        "ICU": "-",
        "frequency": "Every 6 months",
        "action": "If positive/rising: PML risk stratification, consider DMT switch"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild symptoms; able to ambulate safely; reliable follow-up within 1-2 weeks; no IV steroids needed OR completing outpatient infusion; stable baseline function; understands return precautions"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Moderate-severe symptoms; needs IV steroids; functional decline requiring therapy; diagnostic uncertainty requiring expedited workup; unable to care for self at home"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Severe myelitis with respiratory compromise (NIF >-30 declining toward -20); brainstem involvement with airway risk or autonomic instability; severe encephalopathy"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "PLEX needed but unavailable; MS specialist not available for complex decision-making; MRI unavailable for urgent imaging"
      }
    ]
  }
}